0% found this document useful (0 votes)
89 views79 pages

Follicular Salpingitis Overview

This document provides updated objectives for an OBGYN module on labor and delivery. It includes information from module links, powerpoint presentations, textbooks, and UpToDate. The key topics covered are uterine atony, the physiology of labor, intrapartum fetal surveillance including common fetal heart rate patterns, and standardized terminology for documenting patterns. Guidelines are provided for managing different fetal heart rate tracings and determining appropriate clinical responses.

Uploaded by

Hema Laughsalot
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
89 views79 pages

Follicular Salpingitis Overview

This document provides updated objectives for an OBGYN module on labor and delivery. It includes information from module links, powerpoint presentations, textbooks, and UpToDate. The key topics covered are uterine atony, the physiology of labor, intrapartum fetal surveillance including common fetal heart rate patterns, and standardized terminology for documenting patterns. Guidelines are provided for managing different fetal heart rate tracings and determining appropriate clinical responses.

Uploaded by

Hema Laughsalot
Copyright
© All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOCX, PDF, TXT or read online on Scribd

OBGYN Objectives / Module Notes

Updated Objectives 2020

Info is based off of:


- Module links (youtube APGO videos and ACOG Articles)
- VCOM OBGYN Powerpoints linked in the objectives (and posted on the VCOM website)
- Textbook referenced in Syllabus (Beckmann OBGYN)
- UpToDate when all other sources fail

BOLD headings = Objective topics


GREEN highlights = topic is featured in the Module

MODULE 1: Labor & Delivery


APGO Educational Videos:
- Uterine Atony
- Uterine arterioles run through uterus to give blood flow, and after delivery the uterus should contract to
close them off and prevent hemorrhage
- Higher Risk for hemorrhage:
- Low-lying placenta (bc less smooth muscle at the lower part of uterus to contract and close off
arterioles)
- Uterine Atony
- Magnesium (blocks calcium channels >> Ca can’t activate muscle contraction)
- Causes of Atony:
- Uterine Overdistension (interferes with contraction)
- By fetal macrosomia, multiple fetuses, polyhydramnios, distension with blood clots
- Anesthesia
- (causes hypotension >> decreased oxytocin >> decreased contraction)
- Exhausted Myometrium
- By rapid labor, prolonged labor with oxytocin stimulation, chorioamnionitis
- Tx
- Uterine Massage
- Evacuates clots and augments uterine contraction
- Uterine artery ligation
- B-Lynch Stitch over the uterus like suspenders
- Bakri Balloon (inside uterus to give counterpressure against uterine wall)
- Uterotonics
- Oxytocin (Pitocin)
- Released by posterior pituitary
- Given IV (immediate effect) or IM (3-7 minutes to effect)
- Methylergonovine (Methergine)
- 5-HT2 agonist in uterine smooth muscle
- IM (2-5 minutes) or oral (5-10 minutes to effect)
- AE = hypertension (bc causes vasoconstriction; don’t use in hypertensive patients)
- Carboprost (Hemobate)
- Increases free Ca++ >> augments uterine contraction
- AE = diarrhea, bronchospasms (don’t give to asthmatics)
- Misoprostol (Cytotec)
- Physiology of Labor
1. Quiescence (from conception to initiation of parturition)
- Uterine muscle relaxes
- Mediated by Progesterone
- (giving woman weekly Progesterone injections reduces risk preterm labor)
2. Activation (from start of parturition to onset of labor)
- Cervical softening + uterus preps for labor
- Mediated by Estrogen, Progesterone, Uterine stretch
3. Stimulation (from onset of labor to delivery)
- Uterine Contraction + Cervical dilation + fetal / placental expulsion
- Mediated by Prostaglandins, Oxytocin, Relaxin
4. Involution (delivery to restoration of fertility)
- Uterine involution + cervical repair + breastfeeding
- Mediated by Oxytocin (stimulates uterus to contract back and prevent hemorrhage)

Module Notes:
- Articles:
- Azithromycin Prophylaxis in C-sections reduce the risk of post-op infections
- More effective than placebos
- Prevention of GBS early-onset in Neonates
- Screen all women for GBS at 36-38 weeks
- Give all GBS+ women at 36-38 weeks prophylactic antibiotics
- IV intrapartum PCN prophylaxis works the best (not oral or IM)
- Or IV Ampicillin
- PCN allergy >> 1st Gen Cephalosporins (Cefazolin)
- But best to verify via allergy screening and give PCN if possible
- High risk anaphylaxis >> Clindamycin
- IV Vanco if GBS isolate is not susceptible to Clindamycin
- Bloody Show = thick vaginal discharge of mucus and blood from the cervix, caused by rupture of small blood
vessels in the cervix as it effaces and dilates
- Normal part of pregnancy

Intrapartum Fetal Surveillance


- Basic EFM Patterns using Systemic Approach
- Fetal HR (FHR) measured by
- Doppler / Toco externally (measures frequency)
- or Fetal Scalp Electrode / IUPC internally (measures frequency + strength)
- Fetal Heart Monitory (FHT)
- systematically comments on the following in order:
- Baseline
- Variability (absent, minimal, moderate, marked)
- Presence of Accelerations
- Presence of Decelerations (Variable, Early, Late)
- Contraction Frequency
- “Reactive” means:
- ≥ 2 accelerations within 20 minutes
- + moderate variability
- + No decelerations
- Variability = fluctuations in FHR of 2 cycles / minute or more
- Amplitude of peak-to-trough in bpm
- Absent = no amplitude range
- Minimal (DECREASED) = < 5 bpm amplitude
- Causes = hypoxemia, acidosis, sleep cycles, drugs, prematurity, arrhythmias, fetal
tachycardia, etc
- Moderate (NORMAL) = 6-25 bpm amplitude
- Marked (INCREASED) = > 25 bpm amplitude
- Causes = fetal stimulation, transient hypoxemia, sympathomimetic drugs
- Acceleration = abrupt increase in FHR from most recently calculated baseline (onset to peak in < 30s)
- Duration of accel = time from initial change in FHR from baseline to return to baseline
- < 32 weeks: acme (peak) of 10+ bpm above basline with duration 10 seconds - 2 minutes
- > 32 weeks: acme 15+ bpm above baseline for 15 seconds - 2 minutes
- Prolonged Acceleration = lasts 2 - 10 minutes (> 10 minutes = baseline change)
- Variable Deceleration = abrupt decrease in FHR ≥ 15 bpm, lasting 15 seconds - 2 minutes
- that takes < 30 seconds from onset of decel to nadir (lowest point)
- Causes
- Cord compression
- Rapid vagal stimulation (like head compression)
- Cord prolapse (if immediately after rupture of membranes)
- Hypoxemia / Acidosis (if associated with diminished or absent FHR variability)
- Prolonged Deceleration = lasts 2 - 10 minutes
- (can be bad...need immediate response)
- By cord compression, maternal hypotension / hypoxemia, head compression, amniotic fluid
embolism
- Early Deceleration = gradual decrease in FHR with onset to nadir ≥ 30 seconds, and Nadir matches the
peak of the contraction
- Good finding; no response needed
- Causes = head compression, vasovagal response
- Never hypoxemia/acidosis
- Late Deceleration = gradual decrease with onset to nadir ≥ 30 seconds, and nadir is after the peak of the
contraction
- Not reassuring
- Causes = uteroplacental insufficiency (UPI), decreased uterine perfusion / tone, decreased
placental function, maternal hypotension / hypertension, IUGR, maternal diabetes, tobacco
use
- Tachycardia = > 160 bpm
- By maternal fever, fetal hypoxemia, sepsis, chorioamnionitis, fetal anemia, hydrops, maternal
hyperthyroidism, drugs
- Bradycardia = < 110 bpm
- If < 90 bpm, need prompt investigation + resolution or delivery
- Hypoxemia, maternal hypotension / hypoglycemia, cord compression, amniotic fluid embolism,
hypothermia, congenital heart block
- Sinusoidal Pattern = regular, smooth, undulating, sine-like wave in FHR baseline with frequency of 3-5 cycles /
minute persisting ≥ 20 minutes
- By severe fetal anemia, Rh isoimmunization, hemolytic disease, acute blood loss, fetal
hypoxemia/acidosis, maternal narcotic use
- Pseudosinusoidal Pattern = transient, less uniform, and not associated with adverse outcomes
- Contraction Frequency = # contractions in 10 minutes, averaged over 30 minutes
- Normal: ≤ 5 contractions in 10 minutes (averaged over 30 minutes)
- Montevideo Units (MVU) = total intensity of each contraction in a 10 minute period
- MVU > 200 is adequate for most labors to progress

- Standardized Terminology to appropriately document patterns


- Management of EFM Patterns
- NICHD Categories of FHR Tracings
- Category 1 = NORMAL acid-base status (no intervention required)
- Baseline normal (110-160)
- Variability Moderate
- +/- accelerations
- NO late/variable decelerations (early are ok)
- Category 2 = INDETERMINATE (>> surveillance and reevaluation)
- Include:
- Baseline: bradycardia or tachycardia
- Variability: minimal, absent, marked
- Accelerations: absent after fetal stimulation
- Decelerations: variable, prolonged
- Category 3 = ABNORMAL acid-base status (>> prompt evaluation / intervention)
- Include:
- Absent variability + any of:
- late decelerations
- recurrent variable decelerations
- Bradycardia
- Sinusoidal pattern

Intrapartum Care
- True v. False Labor Signs / Symptoms
- True Labor = painful uterine contractions + cervical dilation
- Braxton Hicks contractions = painful contractions felt, but no cervical dilation (false labor)
- When to see OB for evaluation of contractions:
- Leakage of fluid
- Vaginal bleeding
- Painful contractions every 5 minutes for 1 hour
- Decrease in fetal movements
- Pain Management Approaches during Labor
- Stage 1: pain from contraction of uterus / cervix dilation (visceral pain from T10 - L1)
- Stage 2: pain from fetal head descending to lower birth canal and peritoneum (somatic pain from
S2-4)
- Epidural Block
- infusion of anesthetic into epidural space
- Benefits = covers labor AND delivery; maintain sense of touch / motor ability for participation
in labor
- Risk = post-dural puncture headache
- Spinal Block = single injection of local anesthetic (lasts 2 hours)
- Benefit = limited duration for C-section / rapidly-progressing vaginal deliveries
- Risk = postdural puncture headache
- Local Block = local injection into perineum or vagina
- Benefit = enough for episiotomy or laceration repair
- General Anesthesia = inhaled / IV anesthetic >> maternal loss of consciousness
- Only for emergency C-sections
- Risk = maternal aspirations, Neonatal depression
- IV Narcotics (Opioids and Opioid agonists)
- But are systemic, so pain relief is via sedation in this method
- Initial Assessment of Laboring Patient
- Fetal Heart Tones (by EFM or intermittent auscultation)
- Presentation (vertex or breech)
- By abdominal US or exam
- Sterile Vaginal Exam
- For dilation, effacement, and station
- Dilation = opening of internal os of cervix
- Complete dilation = 10 cm
- Effacement = distance between internal and external os
- Non-effaced = about 4 cm thick
- 50% effaced = 2 cm
- Completely effaced = 0 cm thick
- Station = fetal presenting part in relation to ischial spine
- 0 station = presenting at level of ischial spines
- +1, +2, +3 station = 1, 2, 3 cm below ischial spine (to +5)
- -1, -2 station = still 1, 2 cm above ischial spine
- External Tocometer (to assess uterine activity)
- 4 Stages of Labor + Steps of Vaginal Delivery
- Stage 1 = Cervical Dilation (onset to 10 cm)
- Latent Phase = from cervical dilation to 4 cm dilated
- Active Phase = from 4 cm dilation to more rapid dilation (1.2-1.5 cm/hr)
- Walking more comfortable than supine
- Decreased GI motility (so limit solid food intake or else >> nausea/vomiting)
- Mom may feel urge to push when the fetal had descends to put pressure on the
perineum, but don’t push until the cervix is completely dilated
- Stage 2 = Complete Dilation to Delivery of infant
- Pushing can begin, at onset of each contraction
- First delivery, may push for 2-3 hours
- Shorter if laboring without an epidural
- Shorter on subsequent vaginal deliveries
- If low-risk, mom can rest 1-2 hours if she doesn’t yet feel the urge to push
- Delivery
- imminent when half-dollar sized vertex is visible in between pushes
- Steps:
- Ritgen Maneuver = support perineum with one hand and vertex of head with
other hand
- and facilitate extension of the head
- Restitution (head realigns with shoulders)
- Delivery of anterior shoulder then posterior shoulder
- Skin to skin contact with baby on maternal chest
- Stage 3 = Delivery to Placental Delivery
- Active Management Immediately Postpartum:
- Fundal Massage
- Gentle Cord Traction (avoid inversion of the uterus)
- IV / IM Oxytocin
- Placenta Delivery
- can take up to 30 minutes (can wait for uterus to spontaneously expel placenta)
- 2 signs of placenta separating from uterus:
- Gush of Blood
- Lengthening of Umbilical Cord
- Stage 4 = first 2 hours after delivery of placenta
- Palpate uterus to make sure it’s firm/contracted
- Uterine Massage, Oxytotic agents prn
- Examine Placenta to make sure it’s intact and completely removed
- Inspect Birth Canal
- Repair Lacerations with absorbable sutures
- Monitor amount of blood loss via perineal pads, BP, pulse
- Operative Delivery
- = forceps or vacuum retraction
- Indications
- Prolonged / arrested Stage 2 (complete dilation until delivery)
- Suspicion of immediate or potential fetal compromise
- Shortening of Stage 2 for maternal benefit
- Contraindications
- < 34 weeks (risk fetal hemorrhage)
- Fetal bone demineralization condition (osteogenesis imperfecta)
- Bleeding disorder (hemophilia, vWD, thrombocytopenia)
- Fetal head unengaged or in unknown position
- Common Complications
- Maternal Deaths
- 99% maternal deaths occur in developing countries
- Highest risk = adolescent girls
- Major Complications (accounting for 75% maternal death)
- Bleeding
- Infection
- High BP
- Delivery Complications
- Unsafe abortion
- Lacerations
Complications of Pregnancy
- (I) Abnormal Labor
- Causes / Methods of evaluating abnormal labor patterns
- External Tocometer (tells frequency of contractions)
- IUPC (tells frequency + Strength of contractions)
- Fetal Heart Tones
- Montevideo Unit (MVU) = amplitudes above the baseline added together for 10 minutes
- Normal = MVU > 200
- Normal Labor requires:
- Power of regular uterine contractions (to dilate cervix and push fetus down)
- Progression of Labor
- Nulliparous women: > 1.2 cm / hour in active labor
- Multiparous woman: > 1.5 cm / hour in active labor
- Passenger (fetus)
- Not too big
- Good position (so can fit through pelvis)
- Palpate Anterior fontanelle (diamond shape) and Posterior fontanelle (triangular
shape) + sagittal suture
- Occiput Anterior (best position bc smallest part of head coming through first)
- Posterior fontanelle (triangle) palpated at anterior of mom’s body
- Passage (nothing obstructing the birth canal)
- Abnormal Labor Patterns
- Protraction Disorder (slow labor)
- Stage 1 slow (cervix not dilating)
- Nulliparous > 20 hours
- Or rate < 1 cm/hour
- Multiparous > 14 hours
- Rate < 1.2-1.5 cm / hour
- Management:
- Observation or Sedation
- Stage 2 slow (pushing too long)
- > 3 hours with regional anesthetic
- > 2 hours without regional anesthetic (or descending rate < 1 cm/hour)
- Mx:
- Observation, Amniotomy, Oxytocin, augmentation
- C-section if maternal or fetal status becomes nonreassuring
- Arrest Disorder (halted labor)
- Stage 1: no dilation for > 2 hours (or 4 hours with regional anesthetic)
- Stage 2: no descend after 1 hour of pushing

- Failure to Progress = arrest of dilation


- Nulliparous woman < 1.2 cm / hour; or multiparous < 1.5 cm / hour
- Augmentation = stimulation of uterine contractions
- Amniotomy = rupture of amniotic membranes
- Can >> prostaglandin release to help contractions
- Oxytocin
- But titrate so you don’t cause uterine tachysystole
- Arrest of Descent
- Fetal size > 4500 grams
- >> greater risk shoulder dystocia / labor dystocia
- Suboptimal Presentations
- Occiput Transverse = (baby’s head sideways)
- occiput on one side and anterior fontanelle on opposite side
- Occiput Posterior
- Face presentation
- Compound presentation
- Cephalopelvic Disproportion (baby’s head not proportionate to mother’s pelvic size)
- Uterine Tachysystole = 5 contractions / 10 minutes for 30 minutes
- Shoulder Dystocia = Baby’s shoulder caught behind pubic symphysis
- Have 5 minutes to deliver well-oxygenated term infant
- Risk = brachial plexus injury
- Turtle Sign = baby’s head comes out then goes back in (bc shoulders stuck)
- Emergent Management:
- McRoberts Maneuver = hyperflexion + abduction of hips
- Suprapubic pressure downward on anterior shoulder
- Try to deliver posterior arm of fetus
- Episiotomy to open up space posteriorly
- Woodscrew/Rubin maneuver = rotation of fetus to reduce the shoulder
- Move patient to hands/knees
- Last ditch effort:
- Intentional clavicular fracture
- Zavenelli Procedure = push head back in and go to C-section
- Cord Prolapse (umbilical cord prolapsed through the cervix)
- Causes:
- Fetus is not vertex
- SROM or AROM before vertex is well engaged
- SROM = spontaneous rupture of membranes
- AROM = artificial rupture of membranes
- Risk = compression of blood vessels in the cord
- Emergent Management
- Push baby’s head back up, and reduce the cord back into the cavity
- Then go to immediate C-Section
- Leave hand in place on baby’s head with cord inside until immediate C-section
delivery
- Breech Delivery (feet first)
- Three kinds
- Frank = feet near the head
- Complete = legs crossed
- Incomplete = one or both feet are extended

- Emergent Management
- C-Section preferred if available
- Breech Extraction
- Physician reaches hand into uterus and grabs lower extremities of fetus to
gently deliver breech infant

- Avoid traction on fetus (don’t pull the baby out...let mom push it out)
- to avoid fetal head extension, which can make delivery more difficult
- Suprapubic pressure (once baby is delivered to level below umbilicus)
- External Cephalic Version = put pressure on mom’s abdomen to turn the fetus into vertex
presentation (50% success rate)
- Best after 36 weeks gestation (bc spontaneous vertex presentation usually happens
by 36 weeks, and also after 36 weeks they’re less likely to revert back to breech)
- Trial of Labor after Cesarean Delivery (TOLAC)
- Possible Outcomes:
1. Successful TOLAC / VBAC (vaginal birth after cesarean)
2. Scheduled repeat C-Section
3. Failed TOLAC >> end up having to do C-section
- Highest morbidity, bleeding, infection
- Risks
- Uterine rupture (up to 10% risk with hx of classical C-section)
- Difficult labor without assurance of vaginal delivery
- Benefits
- Avoid surgery (less infection, shorter recovery periods)
- Decrease future abnormal placental risks
- Rates of Success:
- Higher rate of success with:
- Prior vaginal birth
- Spontaneous labor
- Higher Failure risk:
- Higher maternal age
- Non-white ethnicity
- Obesity
- Recurrent indication for initial C-section
- higher birth weight
- Gestational age > 40 weeks
- Preeclampsia
- Shorter inter-pregnancy interval
- Complications of Abnormal Labor
- Oxytocin Administration
- For stimulation of uterine contractions
- And post-delivery to prevent uterine atony
- (O) Obstetric Procedures (Indications + Complications)
- Premature Rupture of Membranes = rupture of membranes before onset of labor
- Tests for Rupture of Membranes
- Nitrazine Test = drop of vaginal fluid onto paper strips of Nitrazine dye
- Uses pH to distinguish urine from vaginal secretions
- Amniotic fluid = alkaline (pH > 7.1)
- Will turn dark blue on paper
- Vaginal secretions and Urine = acidic (pH < 6)
- Fern Test = amniotic fluid dries on a slide and causes a fern pattern (due to NaCl in the fluid)
- Ultrasound = if there is less fluid than expected around the fetus, then PROM is possible
- If there’s lots of fluid left, may question if membranes have ruptured
- Dye Injected into Amniotic Sac
- If ROM, then dye will be seen in the vagina within 30 minutes
- Induction / Augmentation of labor
- Indications
- Elective Induction (39+ weeks)
- Postterm pregnancy
- CVD, chronic HTN, Diabetes, Eclampsia, Pre-eclampsia
- Hepatic / Pulmonary / Renal diseaseAsx HIV infection, coagulopathy
- Abnormal FHR, fetal abnormality, fetal growth restriction
- Multiple gestation, Oligohydramnios, Polyhydramnios, PROM, Placental abruption
- Intra-amniotic infection (IAI, chorioamnionitis)
- Poor reproductive history, Prior delivery of stillborn
- Intrauterine death
- Methods:
- Oxytocin
- Cervical Ripening:
- Misoprostol or Prostaglandin E2
- Mechanical dilation using Laminara
- “Sweeping” the amniotic membrane
- Risk of infection, accidental ROM, or bleeding from undiagnosed placenta previa
- Artificial ROM
- Cesarean Delivery
- Prophylactic Antibiotics before C-section
- Cefazolin single dose 60 minutes before skin incision
- Or Azithromycin 500 mg IV if in labor or with ruptured membranes
- Leopold’s Maneuvers
- Epidural / Spinal Anesthesia Placement
- Below L2 (to avoid damaging the SC)
- Vaginal Birth after Cesarean Section
- Spontaneous Vaginal Delivery
- Ultrasound
- Chorionic Villous Sampling / Amniocentesis
- Episiotomy
- Forceps Delivery
- Newborn Circumcision

MODULE 2: Postpartum Care, Fetal Death, Trophoblastic Disease


Module Articles:
- Postpartum Hemorrhage
- ACOG:
- Uterotonic Agents = first line for PPH caused by uterine atony
- Lancet:
- Tranexamic Acid administration in PPH reduces deaths due to bleeding with no adverse effects or
complications

Postpartum Care
- Normal Postpartum Physiology / Care
- Maternal Physiologic Changes of Postpartum Period
- Uterus Contracts down
- To Pelvis in 2 weeks
- Normal size in 6 weeks
- Afterbirth pains (hypertonic uterine contractions in first 3 days)
- Lochia = bloody vaginal discharge, bright red and gets lighter/clearer over 10 days
- Lochia Rubra = menses-like blood (few days)
- Lochia Serosa = more watery-like discharge (few weeks)
- Lochia Alba = yellowish-white discharge (6-8 weeks)
- Vaginal / Vulva soreness
- OTC analgesia
- Pelvic Floor weakness (will improve but may never reach pre-pregnancy state)
- Kegel exercises
- Increased urinary output (due to increased blood flow to the kidneys)
- Normalizes in 2-3 weeks
- Weight Loss
- Immediate 12-15 lbs
- Non-pregnant weight in 6 months
- Menses returns
- in 6-8 weeks if not breastfeeding
- 2-18 months if breastfeeding
- Coagulation
- Pregnancy is procoagulant >> increased risk VTE
- Back to normal in 6-8 weeks
- Normal Postpartum Care
- Monitor: BP, uterine tone (bleeding), urine output (involuntary retention)
- Encourage ambulation (reduce DVT / PE risk)
- Perineal pain (ice packs, sitz baths)
- Breastfeeding support
- Discharge from Hospital:
- 48 hours post-vaginal delivery
- 72 hours post-Cesarean
- Postpartum Patient Counseling
- Breast v. Bottle
- Encourage breast as much as possible for at least 6 months
- Bladder
- Urinary retention
- All women should urinate within 6 hours of delivery or 6 hours of catheter removal
- Urinary incontinence also common
- Bowel: offer stool softeners (especially with lacerations)
- Bleeding / discharge expectations
- “Bottom” (Perineal pain / irritation)
- Blues (postpartum depression history, warning signs)
- Birth Control
- Expect mood changes
- Immunizations
- RhoGAM for Rh- women
- Rubella, Tetanus, Measles, HepB
- Follow up with OB in 6 weeks (physical exam + pap smear)
- Postpartum Contraception
- A new mom CAN get pregnant before she has her first period
- Lactational Amenorrhea < 6 months postpartum if breastfeeding exclusively
- Failure rate 2-5%
- Hormonal Contraception
- Estrogen + Progesterone (ok once milk supply has been established)
- May begin progesterone only at 6 weeks postpartum
- Nexplanon
- Progesterone IUD
- Sterilization (bilateral tubal ligation)
- Postpartum Hemorrhage
- Definition:
- Vaginal > 500 cc
- Cesarean > 1000 cc
- Early v. Late
- Early/Primary PPH within first 24 hours
- By uterine atony, retained placenta, placenta accreta, defective coagulation, uterine
inversion, lacerations
- Late/Secondary PPH 24 hours to 6 weeks
- By retained products of conception, infection, inherited coagulation defects, subinvolution of
placenta site
- Risk Factors
- Polyhydramnios / Multiple gestations
- Prolonged labor / Oxytocin augmentation
- Fast labor
- Chorioamnionitis
- Hx of PPH
- Asian / Hispanic ethnicity
- Causes (4 T’s)
- Uterine Atony (90%)
- Risk Factors
- Fast OR prolonged labor
- Oxytocin induction or augmentation
- Magnesium sulfate prophylaxis
- Chorioamnionitis
- multiple gestation, polyhydramnios, macrosomia, myomas
- Presentation
- SOFT/BOGGY uterus on exam
- Tx:
- Oxytocin + Fundal Massage + Gentle cord traction
- Uterotonics prn (Methergine, Oxytocin, Prostaglandins)
- Bakri balloon, Uterine packing
- Surgery / Hysterectomy (last resort)
- Lacerations (6%)
- Risk Factors:
- Foreceps / vacuum delivery
- Macrosomia
- fast labor/delivery
- Breech
- Retained Placenta (3%)
- RF: placental abnormality (succenturiate, accreta, increta, percreta)
- Risk for accreta: prior Cesarean
- Examine placenta for completeness after delivery
- Remove what’s left digitally

- Coagulation defects
- ITP, TTP, vWF, Hemophilia, HELLP Syndrome, DIC
- Exam: note if blood is clotting, blood oozing from IV punctures, skin wounds / bruising
- Dx:
- CBC, Blood type + cross match, Clot observation test (blood should clot in tube within
8-10 minutes)
- Coag studies (platelets, PT/INR, PTT, Fibrinogen, D-dimer)
- Tx:
- Monitor volume, coag status, replace blood components
- Recombinant Factor VIIa, Clot-promoting drugs
- Uterine Inversion
- PPH + can’t feel uterus (bc it’s involuted)
- Mx = bimanual reduction of uterus
- +/- tocolytics, surgery
- Immediate Management
- Active Management after Delivery
- Fundal massage
- IV / IM Oxytocin
- Gentle Traction on Cord
- Bimanual compression
- Methergine, Prostaglandins
- Intrauterine packing
- Bakri Tamponade Balloon Catheter (puts pressure in inside of uterus)
- Surgical (last resort)
- Uterine / hypogastric artery ligation
- Uterine compression sutures
- Hysterectomy
- Inspection for Lacerations
- And suture / repair
- Coagulopathy management
- FFP + platelets + packed RBCs in 1:1:1 ratio
- rFVIIa
- Sheehan Syndrome (ischemic pituitary necrosis due to severe postpartum hemorrhage)
- >> failure to breastfeed, failure to return to menses
- Postpartum Depression
- Edinburgh Postnatal Depression Scale
- Score > 10 suggests depression may be present
- Postpartum Blues (40-80%)
- Transient symptoms peaking in first 5 days, resolving in 2 weeks
- Rapid mood swings, anxiety, decreased concentration, crying
- Postpartum Depression (5-10%)
- Onset within 4 weeks postpartum
- Symptoms present most of the day, almost every day, for 2 weeks, and impair normal
functioning in life
- All the same criteria of major depressive episode (need 5 including depressed mood)
- Physiology
- Estradiol and Cortisol rise during pregnancy then drop promptly after birth
- Postpartum Psychosis (< 0.5%)
- Severe insomnia, delusions, hallucinations within 2 weeks of delivery
- Treatment
- Psychotherapy (first line)
- Adequate sleep + exercise
- SSRIs first line pharmacotherapy (Sertraline)
- Keep on the same antidepressant if they are already on one and it works well
- Benefits of antidepressants outweigh risks
- Minimal levels reached in breast milk
- Refer to psych if depression worsens (or suicidal / psychosis)
- Postpartum Infection
- Endometritis = infection of endometrium, myometrium, and/or parametrial tissues
- 5% vaginal, 10% cesarean deliveries
- Risk Factors
- C-section
- PROM, Prolonged labor, Retained Placental tissues
- Multiple vaginal exams, especially postmembrane rupture
- Common infections
- MULTIBACTERIAL
- GAS, GBS, Enterococcus, Staphylococcus
- E. coli, Klebsiella, Proteus
- Evaluation
- Abdominal pain
- Foul smelling lochia
- FEVER + UTERINE TENDERNESS
- CBC: Leukocytosis
- Management
- IV Antibiotics until afebrile x 24 hours
- Prevention:
- antibiotics pre-cesarean (Azithromycin)
- GBS prophylaxis
- Minimize vaginal exams after rupture of membranes
Gestational Trophoblastic Disease
- Abnormal proliferations of trophoblasts from the placenta
- Risk Factors
- Advanced maternal age
- History of previous GTD
- Asian, Native American, African
- Molar Pregnancy v. GTN
- Gestational Trophoblastic Neoplasia (GTN)
- Choriocarcinoma = neoplastic syncytiotrophoblast / cytotrophoblast without chorionic villi
- Placenta site trophoblastic tumor = absence of villi with proliferation of intermediate trophoblastic
cells
- Invasive mole = edematous chorionic villi with trophoblastic proliferation that invade into myometrium
- Hydatidiform Moles (Molar Pregnancies)
- Non-invasive tumors from proliferation of trophoblastic tissues (due to abnormal fertilization events)
- Partial = two sperm fertilize haploid ovum
- Karyotype 69XXX or 69XXY
- Fetal components often present (“partial” molar)
- Uterine size normal or smaller than expected
- Complete = 2 sperm fertilize empty ovum
- 46XX or 46 XY
- Absent fetus (“completely” molar)
- Associated with theca-lutein cysts
- Uterine size larger than expected
- Presentation
- Abnormal vaginal bleeding
- High beta-hCG
- Hyperemesis gravidarum
- Large uterus, large cystic ovaries
- No fetal heart tones
- Diagnostic Methods
- Complete Mole = diffuse echogenic snowstorm pattern on ultrasound
- High beta-hCG + exclusion of pregnancy
- Treatment
- D&C
- Hysterectomy (if don’t want to preserve childbearing)
- Follow Up
- Check beta-hCG levels at:
- 48 hours post-evacuation
- Every 1-2 weeks while elevated
- Monthly for 6 months
- Malignant GTD:
- Refer to specialist
- Evaluate for metastases
- No mets: Chemotherapy +/- hysterectomy
- Mets: refer to cancer specialist + chemo, surgery, +/- radiation

Fetal Death
- Common Causes in each Trimester
- T1: chromosomal abnormalities
- T2: anatomical abnormalities (septate uterus, fibroids, cervical insufficiency)
- Presentation
- Diagnostic Methods
- Management (Medical + Psychosocial)
- Module Articles
- Office Management of Early Pregnancy Loss
- Up to 15% pregnancies end in miscarriage (80% in first trimester)
- Virtually no therapies proven to eliminate miscarriage
- Dx of miscarriage:
- Ultrasound
- Product of conception seen
- beta-hCG levels
- Management
- Expectant management (“wait and see” approach)
- 90% successful passage of products of conception without intervention (though may
take weeks)
- effective for incomplete abortions
- Misoprostol
- Uterine aspiration (preferred over D&C for early pregnancy loss)
- Manual vacuum
- Managing Adverse Birth Outcomes: Helping Parents and Families Cope
- Offer counseling
- Assess for postpartum depression / anxiety
- Physicians may need to seek their own coping support

MODULE 3: STIs, Vaginal Disease, Infertility


Vulvar / Vaginal Disease
- Normal vaginal appearance / secretions
- pH ≈ 4.5

- Vulvovaginitis DDx
- Bacterial Vaginosis (25%)
- Thin white discharge + fishy odor
- pH > 4.5
- + whiff test
- Clue cells
- Treatment = Metronidazole (or Clindamycin)
- Candidiasis (40%)
- Thick white discharge + itching
- Risk Factors: Pregnant, Diabetic, Obese, Antibiotics, Corticosteroids, OCPs
- Anything that keeps vaginal area warm/moist (swimming, panty liners)
- Wet Mount:
- Blastospores
- Pseudohyphae
- + Yeast culture
- Tx = Vaginal Miconazole, Clotrimazole, Terconazole (or oral
- Trichomoniasis (35%)
- Yellow frothy discharge + odor
- By sexual contact (but can survive in swimming pools and hot tubs)
- Screen patients for STDs (gonorrhea, chlamydia)
- Wet Mount (organism)
- Tx = Metronidazole, Tinidazole
- Wet Mount interpretation
- pH
- Normal 4.5
- < 4.5: Yeast
- > 4.5: BV or Trich
- KOH “Whiff” Test
- Add a few drops of KOH to vaginal discharge >> fishy odor (Bacterial Vaginosis)

- Classification of Vulvar Dysplasia


- VIN 1 = lower 1/3 (mild)
- VIN 2 = 1/3 - 2/3 dysplasia (moderate)
- VIN 3 = > 2/3 to full thickness displasia (severe)
- = Carcinoma-in-situ (but not “cancer” yet, as has not broken through to invade other tissues)
- Vulvar Dermatitis
- Contact Dermatitis
- Common irritants
- Shampoo and body wash irritants
- Maxi pads, panty liners
- Creative underwear (cotton underwear is best)
- If itching not better with steroids, then >> biopsy (for dysplasia, cancer)
- Lichen Simplex Chronicus
- Itch-scratch cycle
- Scratching >> mechanical irritation >> epidermal thickening + inflammation
- red/reddish-brown plaques
- Tx = Corticosteroids + education on irritants and avoiding itch-scratch cycle
- Lichen Sclerosus
- Marked inflammation + epithelial thinning
- Itching and burning
- ONLY on VULVA
- Cigarette/Parchment paper skin
- Perianal halo / keyhole distribution
- Tx = topical corticosteroids
- Increases risk for SCC of vulva
- Lichen Planus
- Can affect skin, oral cavity, Vulva OR VAGINA (whereas sclerosis only affects vulva)
- >> vulvar burning/itching, Insertional dyspareunia, Vaginal discharge
- Wickham striae (white lacy network)
- Atrophy
- Bartholin’s Gland Disease
- Vulvodynia

STIs
- STI Screening and Partner Notification Guidelines
- Annually screen all sexually active females < 25
- + annually screen older females with risk factors
- Bacterial Vaginosis
- Presentation
- Discharge odor worse after intercourse
- May be asymptomatic
- Evaluation
- Wet mount: Clue cells, decreased lactobacilli, high WBC
- Fishy odor (especially after KOH added)
- Management
- Metronidazole (or Clindamycin)
- Chlamydia
- Presentation
- Often asx
- Urethritis
- Mucopurulent cervicitis
- Dx = culture, ELISA, PCR
- Tx = Azithromycin (or amoxicillin)
- NOT Doxy in pregnancy
- Gonorrhea
- Presentation
- Often asymptomatic (+/- discharge)
- Dx = NAAT
- Tx = Ceftriaxone + Azithromycin
- + REPORT all cases to health department
- Syphilis
- By Treponema pallidum
- Presentation
- 1˚ = chancre
- 2˚ = rash on hands/soles
- 3˚ = gummas, CNS sxs, ophthalmic / auditory symptoms (neurosyphillis)
- Dx
- Dark field microscopy (spirochetes)
- VDRL, RPR
- LP for neurosyphillis
- Tx = PENICILLIN G (always; if allergic, desensitize)
- Chancroid
- By Haemophilus ducreyi
- Presentation = painful genital ulcer + tender suppurative inguinal LAD
- Dx = clinical
- Tx = Ceftriaxone, Erythromycin, Azithromycin
- Tricomoniasis
- Presentation
- Yellow frothy discharge
- Vulvar itching / burning (strawberry cervix)
- Dx = Wet Mount: trich organisms
- Tx = Metronidazole (or Tinidazole)
- HSV
- Presentation
- Flu-like symptoms (initial infection)
- Painful vesicles >> crust and lyse before healing
- Tx = Acyclovir 7-10 days
- Donovanosis / Granuloma Inguinale
- By Klebsiella granulomatis
- Presentation = painless vascular ulcerative lesions that bleed easily on contact
- Tx = Doxycycline or TMP-SMX
- Lymphogranuloma Venereum
- By Chlamydia trachomatis
- Presentation
- Inguinal / femoral LAD
- (if anal transmission) anal bleeding, constipation, anal spasms
- Can >> abscesses/fistulas if untreated
- Tx = Tetracycline, Erythromycin, Doxycycline

Pelvic Inflammatory Disease


- PID
- Pathophysiology
- Infection of upper genital tract, mostly by Chlamydia trachomatis or Neisseria gonorrhea
- Diagnosis
- 1+ of:
- Cervical motion tenderness
- Uterine tenderness
- Adnexial tenderness
- AND 1+ of:
- Fever > 101
- cervical/vaginal mucopurulent discharge
- High WBC on microscopy of vaginal fluid
- High ESR or CRP
- Lab documentation of cervical infection with Neisseria gonorrhea or Chlamydia
- Management
- Ceftriaxone IM + oral Azithromycin
- Salpingitis
- Pathophysiology
- Presentation
- Diagnosis
- Management
- Long-term Sequelae
- Tubo-ovarian abscess
- Chronic salpingitis
- Pelvic adhesions
Pelvic Pain
- Dysmenorrhea
- Primary v. Secondary
- Causes
- Evaluation
- Management
- Endometriosis
- Presence of endometrial glands + stroma in sites outside the uterus
- Pathogenesis theories
- Retrograde Flow
- During menstruation, glands implant in peritoneum, posterior cul de sac, and ovaries
- Vascular and Lymphatic Dissemination
- Endometrial cells travel through lymphatic/vascular system to distant sites (kidneys, pleural
cavities)
- Coelomic Metaplasia
- Multipotent stem cells in peritoneal cavity develop into functional endometrial tissue
- Explains endometriosis in adolescents prior to onset of menstruation
- Common sites
- Bilateral Ovaries
- Posterior Cul-de-sac (uterosacral ligaments, Rectovaginal septum)
- Round ligament, Fallopian Tubes, Sigmoid Colon
- Presentation
- Dysmenorrhea
- Dyspareunia
- Infertility more common in women with endometriosis
- Dyschezia or Hematochezia
- Exam (may be benign)
- Fixed, non-mobile uterus
- Ovarian endometriomas
- Uterosacral nodularity
- Diagnosis
- Direct Visualization + Tissue biopsy in OR
- Confirmed by 2+ of:
- Endometrial epithelium
- Endometrial stroma
- Endometrial glands
- Hemosiderin-laden macrophages
- scarring and adhesions
- Clear, white lesions
- Powder-burn lesions
- Dark red or blue domes
- Management
- OCP (first line)
- Progesterone therapy
- GnRH agonist (induces menopause)
- Danazol
- Surgery
- Excision, Cauterization, Ablation of visible lesions, Lysis of adhesions
- Hysterectomy or Salpingo-oophorectomy
- Chronic Pelvic Pain
- 10% all referrals to gynecologist
- More prevalent than migraines or asthma in women
- Definition
- Noncyclic pain lasting > 6 months severe enough to cause functional disability or medical care, and
localizes to:
- Pelvis
- Abdominal wall below umbilicus
- Lumbosacral back
- Causes
- Gyn:
- Endometriosis, Malignancies, Ovarian retention syndrome
- PID (18-35% PID patients will develop chronic pelvic pain)
- Adhesions, Leiomyomatas, benign cystic mesotheliomas
- Adenomyosis, Cervical stenosis, Chronic emdometritis
- IBS
- Interstitial Cystitis (pelvic pain, urgency, frequency, dyspareunia)
- Presentation
- Evaluation
- History (symptoms, medical, surgical, menstrual, sexual, psychosocial)
- Ask about depression (significant indicator of response to treatment)
- Carnett Sign = tensing of abdominal wall while raising legs or chin
- Signifies myofascial component to pain
- Cervical Cultures
- Management
- Multidisciplinary: Psychotherapy, Gastroenterology, Urology, PT, Anesthesia
- Treat cause (if known)
- If cause unknown, focus on pain relief
- OCP, GnRH agonists (suppress ovulation)
- Hysterectomy (if non-gynecological causes have been ruled out)
- Psychosocial issues
- *correlation between chronic pain and history of abuse*

Infertility
- Definition
- Infertility = failure of conception after 12 months of frequent unprotected intercourse
- Fecundability = probability of achieving pregnancy in one menstrual cycle (20-25%)
- Subfertile = reduced chances of getting pregnant
- Normal Fertility couples with regular sexual intercourse have 20-25% chance of getting pregnant each
month
- Hypothalamus >> GnRH >> Pituitary >> LH/FSH >> Ovaries >> Estradiol/Progesterone >> Reprod. tract
- Causes (Male v. Female)
- Ovulation Failure (25%)
- Amenorrhea, Oligomenorrhea (irregular)
- Primary ovarian failure
- By infection, surgery, radiation, medication, autoimmunity, Turner syndrome, Menopause
- >> high FSH + low estrogen
- Pituitary Failure (trauma, ischemia)
- Hyperprolactinemia can be sign of pituitary adenoma
- Polycystic Ovaries
- Cystic ovaries
- High LH + low FSH
- excessive androgens (produced by follicles bc of highLH)
- Hirsutism, Acne, Obesity
- Anovulation, menstrual irregularity
- Tx = OCPs, gonadotropins, GnRH analog (suppress LH)
- Age
- Tubal Disease
- Often caused by infection, PID
- Uterine Problems (endometriosis, fibroids, previous surgery)
- Cervical Problems (abnormal mucus quality, damage)
- Evaluation
- Male infertility (need to have good sperm production)
- Semen analysis via masturbation after 2-3 days of abstinence
- Volume, sperm concentration, motility, morphology
- If semen analysis abnormal >> repeat
- If persistently abnormal >> Urologist or Reproductive endocrinologist
- Female Infertility
- Need good oocyte production
- History of regular menstrual cycles?
- Monthly ovulation (daily temperature, LH measuring kits)
- Hysterosalpingogram (for fallopian tube patency)
- Inject dye into uterine cavity, and should see it exit through both tubes
- Pregnancy Test (is the patient already pregnant?)
- FSH, LH, Estrogen
- Prolactin Levels (from pituitary adenoma)
- Ultrasound (for PCOS)
- Laparoscopy (of uterus, tubes, ovaries, adhesions, fibroids, endometriosis)
- Hysteroscopy of uterus (for fibroids, endometriosis)
- Management
- Clomiphene (a selective estrogen modulator)
- Stimulate follicular development in the ovaries
- Purified Gonadotropins (stimualtes follicular development)
- Intrauterine Insemination
- Semen sample is washed, suspended in medium, and injected via catheter through cervix into
uterine cavity
- Assistive Reproductive Technology (ART)
- IVF (99% ART)
- Process
- Stimulate ovaries to produce multiple follicles, then retreive oocytes
- Fertilize and incubate the oocytes
- Transfer embryo(s) to uterus
- 30% risk multiple gestations
- Indications
- Blocked / absent fallopian tubes
- Tubal sterilization
- Severe pelvic adhesions
- Severe endometriosis
- Poor ovarian response to stimulation
- Severe male factor infertility
- Failed treatment with less aggressive therapies
- Pre-implantation Genetic Diagnosis
- Tests embryos for genetic disease (CF, Tay-Sachs) prior to implantation
- Psychosocial issues
- Decreased social support (more common in black women than white / asian women)
- Stress

Sexual Assault / Domestic Violence


- Sexual Assault ACOG Article in Module:
- Screen all women for history of sexual assault
- Medical and Legal requirements exist for physicians evaluating survivors of sexual assault in the acute
phase (specimens, history, emergency contraception prn, STI prophylaxis, documentation, chain of
evidence)
- Recognize consequences of sexual assault (infection, pregnancy, mental health conditions)
- Sexual Assault
- Risk Factors
- Presentation:
- Chronic pelvic pain, Dysmenorrhea, Vaginismus
- Nonspecific vaginitis, Menstrual cycle disturbances, Sexual dysfunction
- Types of Sexual Assault
- Marital Rape = within marital relationship without consent
- Date / Acquaintance Rape = coitus without consent (may have consented to sexual play)
- Or with impaired cognitive function (alcohol, sleep, drugs, etc)
- Aggravated Criminal Sexual Assault = weapons used, lives endangered, physical violence inflicted,
physically / mentally handicapped
- Management of sexual assault
- Screen all patients for history of sexual assault
- Acute care:
- Advise to go immediately to ED or medical facility and not to change clothes, bathe, douche,
urinate, defecate, wash out her mouth, clean her fingernails, smoke, eat, or drink
- Medical
- Informed Consent, Chaperone during pelvic exams (or support person present)
- STD testing, Serology
- STI Prophylaxis prn
- Ceftriaxone IM single dose
- + Azithromycin oral single dose
- + Metronidazole single dose (2 hours after the others)
- (covers Gonorrhea, Chlamydia, and Trich)
- HIV >> 28 day HAART + consult with HIV specialist
- Emergency contraception
- Counseling, Follow up, Referrals prn
- Psychosocial
- Legal:
- DOCUMENT injuries, recording of events
- Collect samples (fingernail scrapings, vaginal secretions, pubic hair, saliva, blood-stained
clothing, etc)
- Reporting to authorities, Security of chain of evidence
- Domestic Violence
- PREGNANCY = period of greatest risk for physical abuse
- RADAR Model
MODULE 4: Antenatal Care
Maternal-Fetal Physiology
- Fetal / Neonatal Circulation (powerpoint in Objectives)
- Formation
- 3rd week: blood vessels + heart begins to form
- 4th week: first heart beat
- 5th week: atria + ventricles form
- Supplies oxygen to organs with high demand (heart, brain, upper body)
- Bypasses organs with lower metabolic demand (liver, lungs, lower body)
- Adult v. Fetal Circulation:
- Fluids/gases move from high to low pressure
- Adult:
- High Pressure in systemic circulation (L heart)
- Low Pressure in Pulmonary circulation (R heart)
- Fetus:
- High Pressure in pulmonary circulation
- Collapsed lungs, constricted vascular tree, high vascular resistance
- To shunt blood to heart / system
- Low Pressure in systemic circulation
- 4 Shunts:
- Placenta
- Low resistance organ (so blood flows there)
- Replaces 4 organs:
- Lungs (gas exchange)
- GI system (nutrition / fluid regulation)
- Liver (Nutrition / waste removal)
- Kidneys (fluid excretion / ion regulation)
- Uterine arteries = mother >> placenta
- Uterine veins = placenta >> mother
- Umbilical arteries (2) = fetus >> placenta
- Deoxygenated blood
- Umbilical vein = placenta >> fetus
- Oxygenated blood
- Ductus Venosus
- Oxygenated blood from Umbilical Vein >> IVC
- Bypasses LIVER
- Lower IVC deoxygenated blood mixes with oxygenated DV
- Lower IVC carries blood from lower extremities (deoxygenated)
- IVC >> Right atrium
- Foramen Ovale
- Between R/L Atria
- R >> L Shunt
- Oxygenated blood from IVC >> Left Ventricle and aorta (via foramen ovale)
- Ductus Arteriosus
- Pulmonary artery >> Aorta
- R >> L Shunt
- High resistance in pulmonary arteries (collapsed lungs) >> low resistance in aorta

- Fetal Hb can carry more O2 than adult Hb (due to gamma chains)


- First Breath caused by:
- Physical stress during birth
- Sudden exposure to external temperature
- Post-birth Hypoxia + Hypercapnia
- Connection with placenta is severed
- CO2 builds up >> signals breath
- Shift from Fetal to Adult Circulation by:
- Newborn Breathing (decreases pulmonary resistance)
- Expansion of lungs >> decreased resistance
- Removal of placenta (increases aortic systemic resistance)
- Closure of Shunts:
- Foramen Ovale:
- High pressure in L atrium pushes back on low pressure R atrium
- Ductus Venosus:
- Cutting umbilical vein >> pressure rises and blood backs up from portal vein
- 1-3 hours after birth, DV smooth muscle contracts to close DV
- >> increased portal vein pressure >> increased liver perfusion
- Ductus Arteriosus:
- Increased O2 and decreased PGE2 >> closure (no more PGE to keep it open)
- Indomethacin if it doesn’t close by itself
- Remnants of Fetal Circulation in Adults:

- Patent Ductus Arteriosus (PDA)


- L >> R shunt (initially)
- No cyanosis in early life, but growth >> late cyanosis
- Eisenmenger syndrome
- L>R shunt >> pulmonary HTN >> R>L shunt (reversal)
- Machinery murmur
- Tx = Indomethacin
- Tetralogy of Fallot
- R >> L shunt
- Pulmonary artery stenosis
- RV enlargement
- Overriding aorta
- VSD
- Early cyanosis (skipping lungs)
- Boot shaped heart
- Tx = dilate pulmonary stenosis + close VSD + reconstruct aorta
- Physiology of Pregnancy (powerpoint in objectives)
- Fertilization
- Sperm moves past follicular cells and attaches to zona pellucida
- Acrosomal Reaction = local digestion of zona pellucida >> sperm can access ovum
- Cortical Reaction = glycoproteins in zona pellucida cross-link and become impermeable to other
sperm
- Oocyte + sperm fuse >> meiotic division
- After Fertilization
- Zygote divides inside zona pellucida and becomes Morula
- Morula stays inside fallopian tube 3-4 days while Progesterone readies the Endometrium for
implantation
- Implantation
- Blastocyst implants 5-7 days after fertilization
- Trophoblasts >> Syncytiotrophoblasts + Cytotrophoblasts >> Chorion that will become placenta
- Syncytiotrophoblasts produce hCG by day 7
- Hormones in Pregnancy
- Estrogen, Progesterone (increased)
- Prolactin
- AFP produced by yolk sac
- Too high: think neural tube defects
- Too low: think Down Syndrome or other genetic defects
- hCG: peaks in first trimester
- hPL (human Placental Lactogen)
- hCS (human Chorionic Sommatolactotropin)
- Hormonal Termination of Pregnancy
- Levonorgesterel (Plan B)
- Protestin-only pill taken right after intercourse (mechanism unknown)
- Stops implantation
- Mifepristone (RU-486)
- Progesterone antagonist + PGE >> induces myometrial contractions
- Up to 49 days after pregnancy
- Parturition
- Oxytocin during labor (contractions)
- Milk Synthesis begins at delivery
- Prolactin (from anterior pituitary)
- Suckling required to keep Prolactin levels high
- Oxytocin >> milk ejection
- Maternal Physiologic / Anatomic Changes @ Pregnancy
- EDD = 40 weeks after LMP
- First Trimester = 0-13 weeks
- Second Trimester = 14-27 weeks
- Third Trimester = 28-40 weeks
- Thyroid
- Overall Euthyroid state, despite changes in thyroid regulation
- beta-HCG
- Thyrotropin-like activity >> rise in free T4 in first trimester
- peaks in first trimester (10 weeks) and decreases until term
- Estrogen
- Thyroxine-binding globulin activity >> rise in total T4 / T3
- But doesn’t change free T4/T3
- CVS
- Increased circulating blood volume (to 45% at 32 weeks)
- Increased CO (HR x SV)
- Increased SV in first half of pregnancy
- Increased HR in second half of pregnancy
- Low BP
- Progesterone smooth muscle relaxation
- Increased vasodilatory substances from placenta
- Supine Hypotension Syndrome
- Low BP when supine, due to growing baby impeding Vena Cava when supine
- Advise women not to lay on back while sleeping, but instead on side
- Heart displaced upward; apex moved laterally (bc diaphragm elevated)
- Exam:
- Distended neck veins (increased volume)
- Systolic ejection murmurs (diastolic needs evaluation)
- S2 split with inspiration
- Respiratory:
- Changes mediated by Progesterone
- Thorax:
- Elevated Diaphragm (growing fetus)
- Increased chest diameter / circumference
- Increased O2 consumption
- Increased Minute ventilation = volume of air taken in per minute
- Increases 30-40%
- Compensated Respiratory Alkalosis
- Bc increased ventilation >> increased CO2
- >> increased bicarb excretion to compensate (normal pH)
- All >> DYSPNEA of pregnancy
- Hematologic:
- Increased blood volume
- Physiologic Anemia
- Bc plasma volume increases 45%, but RBC volume only increases 35%
- Average Hg 12.5 in pregnancy (v. 14 in non-pregnant)
- >> Iron supplements
- 60 mg elemental iron / day
- or 300 mg Ferrous Sulfate / day
- VTE Risk
- Increased clotting factors (fibrinogen)
- Decreased Protein C/S
- >> Edema
- GI
- Progesterone relaxes smooth muscle
- GERD (relaxed LES)
- Gallstones (relaxed gallbladder motility)
- Constipation (less GI motility)
- Nausea / Vomiting
- Related to Progesterone and beta-HCG (highest in first trimester)
- Decreases in 2nd trimester as beta-HCG levels decline
- Hyperemesis Gravidarum = severe N/V in pregnancy
- Growing baby displaces stomach upward >> more GERD
- Dietary cravings
- Generalized Pruritus from cholestasis / increased bile acids
- Hemorrhoids
- Gingival disease
- Renal:
- Enlargement / Dilation of Kidneys + collecting system
- Progesterone >> relaxation of ureters >> dilation
- Mechanical compression of distal ureters >> dilation
- Decreased Bladder Capacity (as uterus enlarges)
- Increased renal plasma flow / GFR
- Increased urinary glucose excretion
- Trace glucose on urinary “dipstick” is normal (but monitor for glucosuria)
- >> urinary frequency, stress incontinence
- MSK:
- Lumbar Lordosis (center of gravity over the legs)
- >> low back pain
- Unsteady gait
- Skin:
- Spider angiomata (torso, face, arms)
- Palmar erythema
- Striae Gravidarum, Hyperpigmentation, Darkened Linea Alba (>> Linea Nigra)
- Melasma (“Mask of Pregnancy”)
- Increased skin nevi (may resolve after pregnancy)
- Increased Sweat + Sebum production
- Hair growth
- Breasts:
- Increase in size in first 8 weeks, then steadily thereafter
- Nipples deeply pigmented
- Tenderness / tingling
- Estrogen/Progesterone >> ductal growth + alveolar hypertrophy
- Colostrum = thick yellow fluid expressed from nipples in latter pregnancy
- Fetal/Placental Physiology
- Umbilical Cord:
- 2 umbilical arteries = fetus >> placenta (deoxygenated)
- 1 umbilical vein = placenta >> fetus (oxygenated)
- Fetal Circulation:
- Umbilical vein >> portal system
- Ductus Venosus (bypasses LIVER)
- Umbilical vein >> portal system >>
- 50% to liver
- 50% >> DV >> shunted to IVC >> R atrium
- Foramen Ovale (bypasses LUNGS)
- Some blood from R atrium >> L atrium >> L ventricle >> aorta (bypasses lungs)
- Rest of blood >> R ventricle >> pulmonary arteries
- Ductus Arteriosus (bypasses LUNGS)
- From pulmonary arteries >> ductus arteriosus >> Aorta (bypasses lungs)
- Aorta >> common ileacs >> internal ileacs >> Umbilical arteries >> placenta
- Placenta: Exchange of O2, glucose, amino acids between mom / fetus
- Effect of Pregnancy on common diagnostic studies

Preconception / Antepartum Care


- Preconception Care
- ACOG Prepregnancy Counseling Article (in Module)
- Ask “Would you like to become pregnant in the next year?”
- Optimize health, address modifiable risk factors, educate about pregnancy
- Manage medical conditions that affect pregnancy (diabetes, HTN, psychiatric illness, Thyroid)
- Review all medications, supplements, herbal products
- Offer screen for genetic conditions
- Immunizations (especially for live ones that can’t be given once pregnant)
- Tetanus, Diphtheria, Pertussis, MMR, HepB, Varicella
- Annual Flu Vaccine
- STI screening
- Infectious Disease exposure (like Zika)
- Alcohol, Tobacco, Drugs, Opioids, etc
- Intimate Partner Violence screen
- Folic Acid supplementation (0.4 mg/day)
- Calcium, Iron, Vitamin A, B12, B, D, other nutrients (need RDA)
- BMI goal in normal range before pregnancy
- Certain Medical Conditions’ effect on pregnancy
- Diabetes (high A1c)
- higher rates fetal malformations (25% if A1c > 11.2)
- Heart, brain, renal, GI, skeletal malformations
- Miscarriage risk (44% if A1c 11)
- Maternal risks: nephropathy, retinopathy,
- SLE (increased risk complications)
- Hypertension
- Risk: Preeclampsia, placental Abruption, IUGR
- Treat severe HTN > 160/90
- Don’t want to lower BP too much or else risk lowering placental perfusion
- Tx:
- CONTRAINDICATED: ACEI, ARBs, direct renin inhibitors
- Methyldopa
- Labetalol
- Screen for HIV, STDs in preconception visit
- Genetic Screening Options in pregnancy
- Screen for:
- Sickle Cell (african descent)
- Beta Thalassemia (mediterranean, southeast asian, african descent)
- Alpha Thalassemia (mediterranean, southeast asian, african descent)
- Tay-Sachs (Ashkenazi Jewish, French canadians, Cajun descent)
- Canavan / Familial Dysautonomia (Ashkenazi Jewish)
- CF (Caucasians of European / Ashkenazi descent)
- If Positive for carrier gene:
- Test father: if both are carriers, then 25% risk of fetus having disease
- (50% chance that they will be a carrier)
- Preimplantation Genetic Diagnosis
- Can test embryos for genetic diseases before implantation
- Chorionic Villus sampling / Amniocentesis
- Test fetus for genetic defect (after conceiving naturally)
- Risk of Advanced Maternal Age in pregnancy
- Medications, Immunizations, and Environmental Hazards in pregnancy
- Vaccines
- No live vaccines during pregnancy (Varicella, Rubella, Pertussis, HepB)
- Give these during preconception visit
- Toxoplasmosis (cat feces)
- Intimate Partner Violence
- Smoking in Pregnancy
- Antepartum Care
- Diagnose Pregnancy
- beta-HCG > 25 can cause positive pregnancy test
- N/V, fatigue, breast tenderness
- Prenatal Visits for low-risk women:
- Timing:
- Intake at < 8 weeks
- First prenatal visit < 12 weeks
- 4 week interval visits until 28 weeks (second trimester)
- 2 week interval visits 28-36 weeks (third trimester)
- Weekly visits > 36 weeks to delivery
- Weight, BP
- Diabetes Screen: 1 hour glucose tolerance test at 24-28 weeks
- Or at initial prenatal visit for obese women
- Fetal Assessment
- FHR (via doppler starting at 12 weeks)
- Chromosomal Screening
- 1st Trimester screen: for Trisomy 18 / 21
- Fetal US (18-20 weeks)
- Non-stress tests (NST)
- If concerned for maternal diabetes, HTN, IUGR
- Measures FHR and accelerations for at least 20 minutes
- Maternal Kick Counts
- Lay on side and should feel:
- 5 movements in 1 hour
- 10 movements in 2 hours
- Fetal Growth
- Fundal Height Measurement (from pubic symphysis to top of fundus)
- Approximates # weeks gestation
- Amniotic Fluid Volume
- Low: if fetus shunts fluid away from kidneys to brain >> decreased urine output
- Fetal Lung Maturity
- Determine Gestational Age
- EDD = 40 weeks after LMP
- Naegele Rule = first day of LMP + 7 days - 3 months
- Gestational age = # weeks elapsed between first date of LMP and estimated date of delivery
- Ultrasound
- Confirms EDD if patient’s cycles are regular
- Or determines EDD if patient’s cycles are irregular
- At 5 weeks: normal gestational sac (transvaginal)
- @ hcg 1000-5000
- 18-22 weeks is best time if only one ultrasound will be done
- Confirms presence of pregnancy; diagnose multiple gestations
- Estimates gestational age
- Confirm cardiac activity
- Evaluate pelvic masses / abnormalities, vaginal bleeding, pelvic pain
- Nuchal Translucency (lucent area behind head in nuchal region)
- Too much = Trisomy 13/18/21, Turner, etc
- Diagnostic Studies/Timing
- Chorionic Villus Sampling
- Done > 10 weeks to provide prenatal diagnosis in first trimester
- Risks / Complications
- Vaginal spotting / bleeding
- Cannot diagnose amniotic fluid disorders (like neural tube defects)
- Benefits
- Can be performed earlier in pregnancy (> 10 weeks)
- Rate of pregnancy loss is the same as midtrimester amniocentesis
- Amniocentesis
- Procedure
- Indications
- Complications
- “Soft Markers” for Down Syndrome on Ultrasound
- Nuchal fold
- Intracardiac echogenic focus
- Mild ventriculomegaly
- Echogenic bowel
- Shortened femur / humerus
- Absent nasal bone
- Pyelectasis
- How to screen for Neural Tube Defects?
- High AFT
- Amniocentesis
- Risk Factors for pregnancy complications
- Smoking (miscarriage, placental abruption, IUGR, preterm, birth defects, SIDS)
- Alcohol (MR, developmental delay, birth defects)
- Drugs, Environmental hazards, Seat belt use
- Excessive weight gain (macrosomia, postpartum obesity)
- Inadequate weight gain (preterm, IUGR, low birthweight)
- Nutritional Needs of Pregnant Woman
- Folic Acid: 0.4 mg/day
- Or 4 grams / day if previous pregnancy with neural tube defects
- Weight Gain Recommendations: based on pre-pregnancy BMI
- BMI < 19.8: 28-40 lbs
- BMI 19.8-26: 25-35 lbs
- BMI 26-29: 15-25 lbs
- BMI > 29: 11-20 lbs
- Avoid:
- Unpasteurized milk, dairy, cold lunch meat products (Listeriosis >> fetal demise)
- Tuna, Shark, King macerel (mercury)
- Herbal remedies (lack of regulation)
- Answers to commonly asked questions about pregnancy, labor, and delivery
- Exercise:
- Avoid exercises with risk of falling / trauma (horseback, wrestling, football), or strenuous
exercise that she did not do prior to pregnancy
- Sex:
- Ok unless Placenta Previa, PROM
- Find comfortable positions
- Travel:
- Airlines allow up to 36 weeks
- Avoid prolonged sitting
- Walk every 1-2 hours for good circulation
- Caution with seatbelts worn low on hip bones
- Teratogenic Meds to avoid:
- ACIEs
- Coumadin
- Isotretinoin
- Ionizing radiation > 5 rads
- CT scan abdomen/pelvis = 3.5 rads (CT head is < 1)
- AXR = 100 - 200 millirads (CXR is 0.02 millirads)
- ACOG Routine Tests during Pregnancy (article in Module)
- CBC, Blood type, UA, Urine culture
- Rubella, Hep B/C, STIs, HIV, TB
- Rh antibody test, Glucose screening test, GBS
- Genetic screens
- Ultrasound exams
- Amniocentesis, Chorionic villous testing (to diagnose birth defects)
- Screening for Infectious Diseases that impact Pregnancy:
- Urine Culture / Bacteremia:
- Can >> preterm birth
- Tx = Ampicillin, Cefalexin, or Nitrofurantoin (for all asymptomatic bacteriuria in pregnancy)
- Hepatitis B:
- 90% risk infection of fetus (>> chronic fatal liver disease)
- Tx
- HepB (-): vaccinate mom during pregnancy
- HepB (+): HBIg to mom
- HBIg + vaccination to newborn
- Hepatitis C:
- There’s no good treatment for this...you can’t do much about it
- (C-section doesn’t prevent transmission; HCIg is no good)
- VDRL / RPR:
- For Syphilis (>> abortion, stillbirth, neonatal death)
- Rash, hepatosplenomegaly, saddle nose, Hutchinson teeth, mulberry molars, saber shins
- Tx = PENICILLIN (ALWAYS...if allergic, then desensitize and still give PCN)
- HIV:
- Tx = HAART + C-section at 38 weeks
- Avoid breastfeeding if possible (developed countries)
- Gonorrhea:
- REPORT all cases
- >> gonococcal ophthalmia
- Tx = Ceftriaxone + Azithromycin (can’t give Doxy in pregnancy)
- + Erythromycin prophylaxis eye drops to newborn
- Chlamydia:
- >> Conjunctivitis, Ophthalmia, Pneumonia (in neonate)
- + endometritis, infertility in mom
- Tx = Azithromycin or Amoxicillin
Ectopic Pregnancy
- DDx of First Trimester Bleeding
- Non-viable Intrauterine Pregancy
- Spontaneous abortion
- Molar pregnancy
- Viable intrauterine Pregnancy
- Physiologic implantation bleeding
- Sub-chorionic hemorrhage
- Ectopic Pregnancy

- Evaluation of First Trimester Bleeding:


- TVUS
- hCG (low = failed pregnancy)
- Hematocrit (if perfuse bleeding)
- Ectopic Pregnancy
- Ectopic implantation outside of endometrial cavity
- 1.5% all US pregnancies
- 98% in fallopian tube
- 70-80% in ambullary portion of fallopian tube
- Risk Factors
- Fallopian tube scarring
- History of Ectopic pregnancy (#1 risk factor)
- Tubal surgeries (ligation)
- Chlamydial infections, PID
- Smoking (slows cilia in fallopian tube)
- Diagnostic Protocols
- High index of suspicion
- Classic Sxs
- Amenorrhea
- Vaginal bleeding
- Abdominal pain
- Serum beta-hCG at 48-hour intervals
- Should increase by 50% over 48 hours
- Vaginal US
- Intrauterine pregnancy should be seen when beta-hCG is 1500-2000
- Treatment Options
- Methotrexate
- Indications
- Must be SAFE for mom
- SUCCESS must be likely
- B-hCG < 5000 ideal
- mass < 3.5 cm
- Absolute Contraindications to Methotrexate:
- Hemodynamic instability
- Liver/Kidney abnormalities
- Active lung disease
- Breastfeeding
- Inability to comply with required follow up beta-hCG testing
- Relative Contraindications (that indicate MTX may not be successful)
- Fetal cardiac activity
- High beta-hCG > 5000
- Large ectopic size > 3.5 cm
- Adverse Effects
- N/V, diarrhea, gastric distress, stomatitis
- Dizziness
- Monitoring Required
- MUST follow up for B-hCG level 4-7 days after procedure (must go down)
- Surgical
- Salpingectomy = removal of entire fallopian tube
- No need for follow up bc the entire pregnancy is removed with the tube
- Salpingostomy = hole made in fallopian tube and pregnancy is removed
- Requires beta-hCG follow up

Spontaneous Abortion
- Spontaneous Abortion
- Abortion = pregnancy loss < 20 weeks gestation
- Miscarriage / Spontaneous Abortion = pregnancy loss in absence of any medical or surgical intervention
- Causes:
- First Trimester: Chromosomal abnormalities
- Second Trimester: maternal systemic disease, abnormal placentation, anatomic anomalies
- Often preventable/treatable causes
- Types
- Inevitable = bleeding / ROM + open cervix
- Incomplete = bleeding + open cervix + passage of some tissue (some may remain in uterus)
- Threatened = bleeding without loss of fluid or tissue (closed cervix)
- No treatment necessary (Reassurance as long as US looks ok)
- Missed = retention of a failed intrauterine pregnancy for some time (often asx)
- Complete = documented pregnancy + spontaneous passage of all contents of uterus
- No intervention needed (the abortion is complete)
- Management
- Threatened and Complete:
- No management needed
- Incomplete, Inevitable, and Missed:
- Expectant (watch + wait)
- Medical (Prostaglandins)
- Surgical
- Curettage
- Vacuum
- RhoGAM for Rh- mothers
- Counseling
- Emotional support (short and long-term) for both patient and spouse
- Reassurance
- that the loss was not precipitated by anything they did / didn’t do
- That a single loss does not significantly increase risk of future losses
- Follow up 2-6 weeks
- Recurrent Abortion = 2+ losses
- First trimester = usually genetic/autoimmune factors
- Can consider chromosomal evaluation if recurrent first trimester losses
- Second trimester = usually anatomic abnormalities
- Septic Abortion
- Causes
- Complications
MODULE 5: Reproductive Physiology; Breast and Cervical Disorders
Female Reproductive Physiology
- Hypothalamic-Pituitary-Ovarian axis
- Hypothalamus >> [GnRH] >> Pituitary
- Pituitary >> [LH, FSH] >> Ovaries
- Ovaries >> Estrogen / Progesteron >> reproductive tract / organs
- Natural Suppression of HPO axis:
- Before puberty
- Lactation
- Diet-induced (Anorexia, Malnutrition)
- Excessive Exercise
- Estradiol Production
- LH signals Theca cells to produce Androgens
- Granulosa cells convert androgens to estradiol
- Oocyte Development
- Primordial Germ Cells (oogonia) >> Mitosis that stops in fetal life
- Then all enter meiosis and arrest in meiosis 1 at puberty
- FSH stimulates development from Meiosis 1 to Meiosis 2 (halted again until fertilization)
- Phases of Menstrual Cycle
- Day 1 = onset of menstruation
- Follicular Phase
- Early follicular phase:
- low Estrogen/Progesterone feeds back >> increase GnRH >> increase FSH/LH
- Mid Follicular phase
- Granulosa cell hypertrophy >> lots of Estrogen (by FSH)
- Eventually Estrogen will negatively feedback to hypothalamus / pituitary to lower
FSH/LH
- Late follicular phase
- Estrogen causes thickened endometrium + change in cervical mucus consistency
- Estrogen changes from positive to NEGATIVE feedback
- Dominant follicle is selected
- 30-50 follicles start growing 2-3 months before start of each menstrual cycle, but only
1 is selected and becomes the “dominant” follicle that will ovulate
- As each follicle grows, it produces increasing amounts of estradiol
- Increased amounts of estradiol sends negative feedback to pituitary
- Inhibin >> suppresses FSH from the pituitary
- As follicles grow, FSH levels fall due to negative feedback
- Small follicles are very dependent on FSH, so only the largest will
survive as FSH levels fall (and will ovulate)

- Polycystic Ovaries
- Pituitary >> high LH + low FSH >> disturbed follicle growth
- String of follicles/pearls in ovaries
- Anovulation
- High LH >> androgen secretion
- Hirsutism
- Ovulation (after LH spike)
- with high enough estradiol levels from ovary, pituitary secretes LH surge
- Ovulation happens 36 hours after LH surge
- Oocyte completes Meiosis 1 and arrests in Meiosis 2
- Spike in Body Temp right after ovulation
- Luteal Phase (Progesterone + estradiol)
- Always 14 days (fixed)
- The Ruptured follicle becomes the corpus luteum which secretes Progesterone
- LH >> Progesterone secretion

- LH secreted in the luteal phase keeps signaling the CL to secrete Progesterone


- Steroid negative feedback from CL keeps LH/FSH relatively low
- Eventually CL’s sensitivity to LH decreases, and CL breaks down
- >> loss of negative feedback
- >> FSH and LH on the rise again to start new cycle / Follicular development
- Phases of Endometrium
- Proliferative
- Estradiol causes increase in thickness
- Secretory
- Increased secretion from glands
- Onset of Menstruation = when Progesterone levels fall
- Gradual reduction in blood flow to superficial layers >> hypoxia and damage >> constriction of spiral
arteries (that eventually reopen and rupture)
- Menopause
- Absence of menses for 12 months
- High FSH, LH
- Average age 51.4
- Premature Ovarian Failure = < 41 years old
- Presentation
- Hot flashes, mood lability, vaginal dryness, dyspareunia, urinary symptoms

Embryology and Pelvic Anatomy


- Define:
- Perineum = surface of the trunk between the thighs and buttocks, extending from the coccyx to the pubis
- Vulva = labia majora, labia minora, mons pubis, clitoris, vestibule, and ducts of glands that open into the
vestibule
- Labia majora = folds of skin with underlying adipose tissue fused anteriorly with mons pubis at the perineum
- Labia minora = narrow skin folds lying inside the labia majora
- Clitoris = anterior to labia minora; embryologic homologue of the penis
- Urogenital Diaphragm = triangular shaped diaphragm that lies on the anterior part of the pelvis between
ischiopubic rami

- Embryology/Development of External Female Genitalia


- Cloaca is formed from dilatation of caudal end of hindgut, and covered by cloacal membrane
- Urorectal septum separates the cloaca into the urogenital sinus (anteriorly) and anorectal canal (posteriorly)
- Septum forms mesoderm in pelvic floor that grows down to reach the cloacal membrane
- Genital tubercle develops at cranial end of cloacal membrane
- Labioscrotal swellings + urogenital folds appear on each side of cloacal membrane
- ESTROGEN presence + ABSENT ANDROGENS >> external female genitalia
- Genital tubercle >> clitoris
- Unfused urogenital folds >> labia minora
- Labioscrotal swellings >> labia majora
- Embryology/Development of Ovary
- 5th week of gestation: Primary sex cords project from surface of gonadal/genital ridges in embryo
- 6th week: primarordial germ cells migrate into gonadal ridges and associate with sex cords
- Primordial germ cells will become oogonia
- 10th week: gonad has developed into an identifiable ovary
- Primary sex cords degenerate, and secondary sex cords appear (“cortical cords”)
- 16th week: cortical cords organize into primordial follicles (each with an oogonium)
- Uterus
- lies between the bladder + rectum
- Components of the Uterus
- Cervix
- Body of Uterus
- Endometrium (simple columnar epithelium)
- Myometrium (smooth muscle)
- Serosa (connective tissue)
- Uterine Ligaments
- Round Ligament: travels through the inguinal canal
- Suspensory Ligament: holds ovarian artery + vein
- Ovarian Ligament (proper ovarian ligament)
- Broad Ligament: extension of parietal peritoneum
- Covers body of the uterus
- Blood supply to Pelvis
- Iliac artery >> internal/external iliac artery (at pelvic brim)
- Anterior division of internal iliac:
Internal pudendal Obturator
Inferior gluteal Uterine
Vesical Vaginal
Middle rectal
- External iliac artery ultimately >> Femoral artery
- Inferior epigastric artery branches in pelvis and traverses abdomen
- Need to avoid at laparoscopy port placement
- Path of Ureter in Pelvis
- Under ovarian vessels at pelvic brim
- Then crosses uterine artery as it enters the uterus
- Watch out for ureter during pelvic surgeries
- Muscles of Pelvic Floor
- Pelvic Diaphragm
- Levator Ani (critical to support pelvis and prevent organ prolapse)
- Puborectalis + Pubococcygeus + Ileococcygeus
- Coccygeus
- Perineal membrane + Perineal body (inferior to pelvic diaphragm)

- Bony Pelvis
- Greater (False) Pelvis
- Distributes weight of abdominal organs, and supports uterus at term
- Formed by:
- Lumbar vertebrae
- Posterior iliac fossa
- Abdominal wall
- Lesser (True) Pelvis
- Contains pelvic organs (uterus, vagina, bladder, fallopian tubes, ovaries, rectum, anus)
- Formed by:
- Sacrum / coccyx (posterior)
- Ischium / pubis (anterior)
- Pelvic Measurements:
- True Conjugate (Obstetric) Diameter = sacral promontory >> widest part of pubic symphysis
- Narrowest distance through which baby has to traverse
- Should be at least 11 cm to ensure delivery of fetal head
- Diagonal (false) Conjugate Diameter = sacral promontory >> inferior margin of pubic symphysis (pelvic
exam)
- Anatomical Conjugate Diameter = sacral promontory >> superior margin of pubic symphysis

- Pudendal Block:
- Pudendal artery = at level of ischial spines
- So give block below the ischial spines to avoid pudendal nerve and arteries
- Vulvar innervation
- Mostly by pudendal nerve
- But anterior to the urethra: ilioinguinal + genitofemoral nn.
- MC site of Ectopic Pregnancy
- Ampulla (bc past the ampulla is the isthmus which is very narrow and fetus can’t fit as well there)
- Ovarian Torsion
- Ovary twists on IP Ligament (infundibulopelvic ligament) >> cuts off main blood supply
- IP ligament carries:
- Ovarian arteries (branch of abdominal aorta)
- Ovarian veins (drain to IVC on R, into left renal vein on left)

OBGyn History and Exam


- Thorough OBGyn History
- Assess Health Risks
- Unintended pregnancy, STIs, cervical pathology, breast/gyn malignancy
- Domestic Violence
- Health Literacy
- Assess compliance with Screening
- Gyn exam (cervix + ovaries)
- Breast exam, imaging
- Osteoporosis
- Cholesterol / Diabetes
- Colon Cancer
- OB History
- G’s and P’s:
- Gravida = # pregnancies
- Nulli-, Prima-, Multi-, Grand multi-gravida
- Parity = # births
- Nulli-, Prima-, Multi-para
- TPAL
- Full Term
- Preterm
- Abortion
- Living
- Examples:
- if 4 pregnancies, 3 born full term, and 1 miscarriage: G4 P3013
- Currently pregnant; 1 prior ectopic pregnancy: G2 P0010
- 3 pregnancies; 1 was miscarriage and others were full term and living: G3 P2012
- 1 prior pregnancy that was full term and is living: G1 P1001 (or G1P1)
- 1 prior pregnancy of twins born at term and living: G1 P1002
- Parturient = currently in labor
- Puerpera = recently gave birth
- Outcomes of Pregnancy
- Full Term = ≥ 37 weeks
- Preterm = < 37 weeks
- Abortion (induced, spontaneous, Ectopic, Molar)
- Living currently
- Gyn History
- Menstrual history
- Normal Cycle: q21-35 days with flow ≤ 7 days (average flow < 60 mL)
- Menorrhagia = flow > 7 days,or > 80 mL
- Metrorrhagia = irregular
- Menometrorrhagia = heavy, irregular
- Polymenorrhea = < 21 days between periods
- Dysmenorrhea = painful menses
- Age of menarche + Age of Menopause
- Current cycle characteristics
- First day of LMP
- Frequency, Duration, Amount estimate of flow
- Symptoms associated
- Pap smear History
- Date + Results of most recent
- Prior abnormal results (+ evaluation, diagnosis, treatment, follow up)
- Contraceptive history
- Methods + dates
- Complications
- Reasons for changes
- Sexual history
- Gyn infections (STIs, risk factors, results of screening tests)
- Dyspareunia
- Current/past abuse or assault
- Sexually active? Men, women, or both? Condoms?
- How many lifetime partners?
- History of STI?
- Infertility history
- Gyn surgical procedures
- Hysteroscopy, Laparoscopy, Hysterectomy, Oophorectomy, Myomectomy
- Bilateral tubal ligation
- Documentation and Oral Reporting of Results
- Gain Patient’s confidence and cooperation, and assure comfort and modesty
- Quiet, private, well lit room
- With patient dressed whenever possible
- Cover intimidating instruments possibly
- Presence of family members may impede interview
- Painless Exam
- Can tell patient to breathe in through nose and out through mouth, and relax muscles
- “Try to relax as much as you can, although I know that is alot easier for me to say than for you to do”
- “Let me know if anything is uncomfortable, and I will stop and we will try to do it differently”
- Talk before you touch: “I am going to touch you now” to alleviate surprises
- Education regarding Breast self-examination
- Encouraged so that women know what their normal breasts feel like (can lead to earlier detection of masses
/ abnormalities)
- Pap Smear + DNA Probes / Culture (APGO video)
- Cervical cancer worldwide:
- 5th leading cause of cancer
- 4th leading cause of cancer death in women
- Declined 50% in US due to screenings
- Liquid Cytology
- Pap test, HPV PCR, Gonorrhea, Chlamydia
- Nucleic Acid Amplification Testing (NAAT)
- Separate swab of endocervix (or first catch urine sample)
- Pap Smear Guidelines
- Initiation of Pap testing = age 21 (regardless of first sexual activity)
- Age 21-30:
- Pap test + Cytology q 3 years
- Age 30-65:
- Pap test q3 years
- OR Pap + HPV q5 years
- But still need visual and bimanual genital exam regularly
- Age > 65 OR Hysterectomy:
- No pap test required anymore
- History of CIN 2 or higher: screen for 20 years after regression or treatment of lesion
- Annual Health Maintenance Visit (APGO video)
- Screen for:
- Diet, Nutrition, Exercise
- Seat belt use, Sun exposure
- Alcohol / substance use, Tobacco
- Depression
- Contraception, STIs
- Intimate Partner Violence
- Breast Cancer
- Risk Factors
- Age
- FH, Genetics
- Early menarche, Late menopause, late childbearing
- Hodgkin disease, Enlarged thymus
- Dense breast
- Mammogram Screening initiation: 40 years old q2 years
- Colorectal Cancer
- 3rd cause of cancer death in women
- Risk Factors
- Inflammatory Bowel Disease (Crohns, UC)
- FH colorectal cancer or polyps
- Genetic syndromes
- Lifestyle (low fruit/veggies, low exercise, low fiber diet, overweight/obesity)
- Screening Colonoscopy
- Age 50 and q 10 years
- Age 45 for african american women
- Cervical Cancer
- HPV vaccine given from age 9 - 26
- Screening Pap:
- Age 21+
- Age 21-30 by cytology alone q3 years
- Age 30-65 by cytology + HPV q5 years
- Age 65+ or hysterectomy: no longer needed
- History of CIN2 or higher: screen 20 years after regression or treatment of lesion
- Osteoporosis
- Risk Factors:
- Caucasian
- Age
- Low body weight
- FH
- Alcohol, Tobacco use
- Screening DEXA scan
- Age 65
- Or < 65 if:
- Medical history of fragility fracture
- < 127 lbs
- Medical causes of bone loss
- Parental history of hip fracture
- Current smoker
- Alcoholism
- Rheumatoid arthritis
- Dx = T-score < -2.5
- “Low bone mass” = -1 to -2.5
- Normal = > -1
- Skin Cancer
- Risk Factors
- FH
- Atypical nevi; high nevus count
- Sun / UV exposure
- Phenotypic Traits: light skin, red/blonde hair color, high density freckling, light eye color
- Skin Lesion Exam: (ABCDE)
- Asymmetry
- Border irregularities
- Color variations
- Diameter > 6 mm
- Enlargement / Evolution
- Coronary Heart Disease
- Check Cholesterol: LDL, HDL, Triglycerides, Total cholesterol
- Risk Factors for CHD
- FH of hyperlipidemia, Peripheral vascular disease, or premature CVD (< 50 men or <60
women)
- Obesity, Diabetes, Hypertension
- Tobacco
- Dyslipidemia
- high LDL, Triglycerides, and Total cholesterol
- OR low HDL
- Screening Cholesterol assessment
- Age 45 in women, q5 years (unless risk factors)

Breast Disorders
- Breast Anatomy
- Terminal Duct Lobular Unit (TDLU) = lobule of acini that drain milk into terminal duct
- Ducts surrounded by myoepithelial cells to allow for milk ejection
- Standards of Surveillance of an adult woman
- Breast self-exam
- Physical Exam
- Performance of Clinical Breast Exam
- Include inspection of both axillae + entire chest wall
- Mammogram
- For 40+ yo
- Detects lesions 2 years before palpable
- Ultrasound
- For women < 40
- Or for inconclusive mammography findings
- MRI for very high risk women (like BRCA)
- Approach to woman with:
- Nipple discharge
- Bilateral or unilateral? Spontaneous or expressed? Uniductal or multiductal? Color? Mass?
- Cancer more concerning if:
- Bloody discharge
- Unilateral
- >> breast ductography
- Breast pain (Mastalgia)
- Cyclic: associated with Luteal phase of menstrual cycle
- Pain more in outer breasts
- Non-cyclic: no association with cycle
- Drugs, mastitis, tumors, cysts, surgery, idiopathic
- Extramammary pain
- Chest trauma, fibromyalgia, rib fractures, shingles, etc
- Tx
- Tight bra; weight reduction; Exercise
- Danazol (but has lots of side effects)
- Breast mass
- Signs concerning of malignancy:
- Size > 2 cm
- Immobility
- Poorly defined margins
- Firm
- Skin dimpling or color changes
- Retraction or changes in nipple
- Bloody nipple discharge
- Ipsilateral Lymphadenopathy
- BIOPSY suspicious breast masses
- Non-Proliferative Breast Disorders
- Breast Cysts
- Common in women 35-50
- round/ovoid in shape
- Fibrocystic Change
- Cyclic pain
- Nodular tissue
- Dilation of acini and ducts, with dense stroma
- Fibrosis, Adenosis
- Proliferative Breast Disorders WITHOUT Atypia (increase risk BCa by 1.5-2)
- Intraductal Papilloma
- serous/bloody nipple discharge
- < 2 cm from the nipple
- Tx = surgical excision
- Fibroadenoma
- Common age 15-35
- Well defined, mobile mass
- Dense stroma with compressed ducts; well circumscribed
- Tx = observation or excision
- Usual Ductal Hyperplasia
- Increased duct cells, but retain cytological features of benign cells
- No tx needed
- Epithelial Hyperplasia, Sclerosing Adenosis, Sclerosing lesions, Papillomas
- Proliferative Lesions WITH Atypia (Cancer risk 3.7-5.3)
- Atypical Ductal Hyperplasia (ADH)
- Atypical Lobular Hyperplasia (ALH)
- Lobular Carcinoma in-situ (7-10x increased risk BCa)
- Management
- If biopsy shows ADH, ALH, or LCIS >> surgical excision
- Ductal Carcinoma in Situ (DCIS)
- Cells invade ducts but don’t invade basement membrane
- Cohesive, low grade cells
- Microcalcifications on mammogram
- Comedo necrosis = necrosis in the middle of cancer cells
- Tx = excision
- Breast Cancer
- Risk Factors for Breast Cancer
- Age
- Personal history of BCa
- BRCA, FH of early BCa
- High breast tissue density
- Early menarche; Late menopause
- No term pregnancies; First pregnancy after age 30; never breastfed
- Types
- Invasive Ductal Carcinoma
- 70% are Ductal
- DCIS that has invaded the basement membrane
- Invasive Lobular Carcinoma
- “Single file” of cells
- Paget’s Disease of the nipple
- Eczematous patch on the nipple
- Associated with DCIS or invasive breast cancer
- Paget cells: large, pale cells with clear halo
- Presentation
- Mass
- Mammogram abnormality
- Her-2/neu
- Promotes growth of cancer cells (in 25% BCa)
- Good prognosis bc highly responsive to therapy
- Estrogen / Progesterone receptors
- ER+ = better prognosis than ER-
- Metastasis
- Regional LNs, brain, bone, liver, lung, ovaries
- Treatment
- Surgical: Lumpectomy or Mastectomy
- Radiation to reduce local recurrence
- Chemotherapy if high-risk characteristics of the tumor
- Hormone therapy if ER+
- Selective Estrogen Receptor Modulators (SERMs)
- Aromatase inhibitors
- Mastitis

Cervical Disease and Neoplasia


- HPV
- Causes 99.9% cervical cancer worldwide
- HPV 6/11 = more genital warts
- HPV 16/18 = more cervical cancer
- Epidemiology / Risk Factors
- Young (20-24 peak)
- # lifetime sex partners
- Early age of first intercourse
- Male partner sexual behavior
- Smoking
- Uncircumcised males
- Clinical Burden
- Infects 6 million annually in the US
- 75-90% lifetime likelihood of getting genital HPV
- HPV Vaccine
- Options
- Gardasil: quadravalent vaccine that prevents HPV 6, 11, 16, 18
- Cervarix: bivalent vaccine to prevent HPV 16/18
- ACOG Recommendation:
- Routine vaccination for females and males age 9-26
- First dose before age 15 + one dose 6-12 months apart
- OR if first dose is ≥ 15 yo:
- + 1 dose 1-2 months after first dose
- + 1 dose 6 months after first dose
- STILL SCREEN with Pap Smear even if had the vaccine
- Cervical Cancer
- Pathogenesis
- Squamocolumnar Junction = between squamous and columnar cells of cervix
- Descends in menarche to be visible
- Then ascends back up cervix with age
- Neoplasia almost always develops in the Transformation Zone
- Area of immature metaplasia between original and current squamocolumnar junction
- Risk Factors
- HPV (99.9% cervical cancers worldwide)
- OCPs, DES
- FH cervical cancer
- Hispanic, African American
- Immunosuppression (HIV, drugs, autoimmune disorders)
- SMOKING
- Low SES
- Lack of regular cancer screening
- Presentation
- Watery vaginal discharge; intermittent spotting; postcoital bleeding
- +/- visible cervical lesion
- Guidance for Cervical Screening
- First Pap = 21 yo
- < 30 yo: every 3 years
- > 30 yo: every 3 years OR every 5 years with cytology and HPV testing
- STOP screening:
- At 65
- Post hysterectomy with removal of cervix, without prior abnormal Pap
- History of CIN 2 or higher:
- Screen for 20 years after regression or treatment of lesion (even if over 65)
- Annually for high risk patients:
- DES in utero exposure
- Immunocompromised
- History of CIN II / III

- Initial Management for Abnormal Pap test


- >> COLPOSCOPY (biopsy) for diagnosis
- Acetic acid applied to cervix to make dysplastic cells appear white
- Treatment
- LLETZ
- Cryotherapy
- Ablation or Excision
- Closer screening
- Classification Terminology for Cervical Cytology
- Cervical Intraepithelial Changes (CIN)

- CIN1 / LSIL
- Mild atypical changes in the lower 1/3 of cervical epithelium
- Tx
- Observation (if good colposcopy)
- (likely resolves on its own)
- Colposcopy + cytology q6 months until 2 consistent negative Paps (says VCOM
powerpoint)
- Or Repeat Pap smear in 1 year (says ACOG video)
- CIN2 / CIN3
- CIN 2
- Covers lower 1/3 - 2/3 of the cervical epithelium
- HSIL if it’s p16 (+)
- LSIL if it’s p16 (-)
- CIN 3 = HSIL
- Change in > 2/3 epithelium
- 12-40% progress to cancer
- Tx usually recommended
- Ablation (Cryotherapy or Laser ablation)
- Excision (Cone or LEEP)
- Invasive Cervical Carcinoma
- Follows CIN3
MODULE 6: Pregnancy Complications
Preeclampsia / Eclampsia Syndrome
- Types of HTN in pregnancy
- Preeclampsia
- new-onset HTN ≥ 20 weeks
- + proteinuria OR end-organ dysfunction
- Gestational Hypertension
- HTN > 20 weeks without symptoms of preeclampsia
- Chronic Hypertension
- HTN before pregnancy, OR diagnosed ≤ 20 weeks
- Hypertension with Superimposed Preeclampsia
- chronic HTN + symptoms of preeclampsia
- Preeclampsia-Eclampsia
- Eclampsia = seizure onset in a woman with preeclampsia
- Pathophysiology
- By Maternal vasospasm
- Risk Factors for Preeclampsia
- History of Preeclampsia in previous pregnancy
- FH of preeclampsia (first degree relative)
- Primiparity
- Multiple Gestation
- Pre-exiting HTN, DM, Obesity
- Renal disease, hypercoagulability, SLE
- > 40 yo
- Presentation / Diagnosis
- Dx requires:
- High BP
- > 140/90 on two occasions > 4 hours apart after 20 weeks gestation
- + Proteinuria
- > 300 mg/24 hour urine
- Protein/Cr ratio > 0.3
- Dipstick 1+
- OR high BP + systemic findings of end-organ dysfunction
- Platelets < 100K
- Cr > 1.1
- LFTs 2x normal
- Pulmonary edema
- Cerebral / visual symptoms
- Management
- Preeclampsia
-Delivery at 37 weeks if no severe features
-Close surveillance until 37 weeks gestation
- BP, serum, urine (for progression)
- BP meds if > 160/110
- Hydralazine, Labetalol, or Nifedipine
- US for fetal growth / evidence of restriction
- NSTs twice a week
- Betamethasone if < 34 weeks (for fetal lung maturity)
- Preeclampsia with Severe Features
- Delivery at 34 weeks if severe features (or even earlier if worsening symptoms)
- C-section not necessarily required
- determined by presentation, FGA, cervical status, maternal/fetal conditions
- “Severe Features”:
- Uncontrollable severe HTN
- Eclampsia
- Pulmonary edema
- Abruptio placentae
- DIC
- Nonreassuring fetal status, Intrapartum fetal demise, Nonviable fetus
- Magnesium Sulfate (for seizure prophylaxis)
- Eclampsia
- STABILIZE MOM first (will help to stabilize fetus)
- IV Magnesium sulfate (for seizures)
- Delivery Now (again, C-section is not required)
- Complications
- Maternal:
- Morbidity / Mortality (a leading cause, 50-60K / year worldwide)
- Eclampsia (before, during, or after labor)
- HELLP syndrome
- Placental abruption
- Stroke, Liver damage, Kidney injury, ARDS
- Fetal:
- Growth restriction
- Preterm labor
- Placental abruption
- HELLP Syndrome
- Hemolysis + Elevated Liver enzyme + Low Platelets
- Presentation
- Persistent edema unresponsive to resting in supine position
- May involve upper extremities, sacral region, face
- RUQ pain/tenderness (liver)
- Nausea / vomiting (nonspecific viral-like syndrome)
- Hyperreflexia on DTRs
- Clonus at ankle is worrisome
- Diagnosis Criteria
- Microangiopathic hemolysis (Hemolysis)
- Hepatocellular dysfunction (high LFTs)
- Thrombocytopenia (low platelets)
- Management
- Platelets if < 20K
- If < 34 weeks
- try Corticosteroids + Delay Delivery 24-48 hours after Corticosteroids if possible
- If labs or fetal status worsens, go straight to Delivery
- If > 34 weeks, DELIVER

Gestational / Pregestational Diabetes


- Gestational Diabetes = carbohydrate intolerance starting with onset of pregnancy
- A1 = diet controlled
- A2 = medication/insulin controlled
- Pregestational Diabetes = diabetic before pregnancy
- Risk Factors
- Prior pregnancy with GDM
- BMI > 30
- Previous macrosomic fetus
- Impaired glucose metabolism (like PCOS)
- Family history
- Asian / Hispanic women
- Screening Protocol
- 50g 1 hour GTT > 200 (done at 24-28 weeks)
- If > 130, do 3 hour GTT
- (don’t need to be fasting)
- HbA1c
- Diagnostic Protocol
- 100g 3 hour GTT:
- Fasting > 95
- 1 hour > 180
- 2 hour > 155
- 3 hour > 140
- Need 2+ abnormal results to diagnose GDM
- Management / Monitoring
- Monitor Glucose:
- Morning + pre- and post-prandial levels throughout the day/evening
- Goals:
- Fasting < 95 (morning)
- 1-hour postprandial < 140
- 2-hour postprandial < 120
- DIET first: 30 kcal/kg per day
- Meds (if uncontrolled by diet)
- Insulin
- Fast-acting (Regular, Lispro, Aspart)
- Intermediate -acting (NPH)
- Long-Acting (Detemir, Glargine)
- Glyburide
- Stimulates insulin secretion from beta cells in peripheral tissues
- *not for sulfa allergic patients*
- Metformin
- Biguanide that improves insulin sensitivity in liver and peripheral tissues
- Delivery induced at 39 weeks if there are no complications
- C-section considered if fetal weight > 4500g
- Consider earlier delivery if indicated
- Constant glucose infusion (5% Dextrose) to maintain glucose at 100 mg/dL
- Glucose drops during delivery
- +/- paired with insulin infusion
- Complications
- Increased Fetal Growth
- Shoulder Dystocia
- Cesarean Delivery
- Severe Perineal Laceration
- Preeclampsia
- Type 2 Diabetes
- Polyhydramnios
- In Neonate:
- Hypoglycemia
- Hypercalcemia, Hyperbilirubinemia
- Polycythemia
- Childhood Obesity
- Adult Type 2 Diabetes

Alloimmunization
- Pathophysiology
- RBCs contain surface antigens (antibodies will attack foreign antigens)
- ABO: Lewis Antigen (“Lewis Lives”)
- ABO Incompatibility >> mild hemolytic response / fetal Hyperbilirubinemia
- RhD: Kell antigen (“Kell Kills”)
- Rh- mom will mount antibody response to Rh+ fetus if exposed to fetal blood during delivery
- Antibodies will attack Rh+ fetus RBCs in subsequent pregnancies
- (antibodies can freely cross the placenta)
- >> fetal hemolytic anemia
- Modes of Sensitization
- Abortion, Ectopic Pregnancy, External Cephalic Version, Hydatidiform Mole
- CVS, Amniocentesis
- Abdominal Trauma
- Abruption / Bleeding Previa
- Childbirth, Delivery of placenta
- Consequences
- Severe anemia >> high output fetal cardiac failure
- >> FETAL HYDROPS
- Skin edema
- Ascites
- Pleural / Pericardial effusions
- Diagnosis
- Indirect Coombs Test
- Coombs+ means the patient has received sufficient antibody (anti-D Ig)
- Blood type screening for every pregnancy
- Doppler Ultrasound (for peak velocity of Middle Cerebral Artery flow)
- in Fetal Anemia, blood will be less viscous due to fewer cells
- So velocity of flow will increase in MCA
- Amniotic Fluid Assessment (for fetal anemia)
- Management / Prophylaxis
- RhoGAM to Rh- women
- RhoGAM = anti-D Ig
- 300 µg given at:
- 28 weeks (or earlier if sensitization even happens)
- 40 weeks if she still hasn’t delivered
- After delivery
- 300 mcg protects Rh- mother from 15 mL RBCs or 30 mL whole fetal blood
- (average fetal blood volume = 350 ccs (like a 12 oz can of soda)
Third Trimester Bleeding
- By Term:
- Blood volume increased 40%
- CO increased 30%
- 20% of this goes to gravid uterus (bad if it starts bleeding)
- Causes
- Serious:
- Placenta Previa, Placental Abruption
- Vasa Previa
- Preterm Labor
- Uterine rupture
- Benign: Vaginal / Cervical Tear, Cervical polyp, Severe Cervicitis
- Evaluation
- ABCs (+ evaluate Baby)
- Fetal Heart Rate
- PPQRST History
- Pain with bleeding?
- Placental location
- Quantity of bleeding
- Recreational drug use
- Sex recently?
- Timing
- Exam
- Vitals (Maternal + Fetal heart signs)
- Petechiae on skin?
- Palpate Uterus (soft, hard, tender?)
- Speculum Exam (for visual examination of cervix)
- NO DIGITAL CERVICAL EXAM until placental location is confirmed
- Placenta Previa = placenta covers the internal os
- Complete or Marginal coverage
- >> painless vaginal bleeding
- Dx
- Ultrasound (placenta seen between fetal head and cervix)
- NO DIGITAL EXAM

- Management
- Volume resuscitation (if heavy bleeding)
- +/- Betamethasone (for lung maturity if < 34 weeks)
- C-section delivery
- Complications
- Bleeding from lower uterine segment
- Abnormal extension of Placental tissue (Accreta, Increta, Percreta)
- Types
- Accreta = into superficial myometrium
- Increta = into myometrium
- Percreta = through myometrium into surrounding tissues
- Risk Factors
- Placental previa
- Previous myomectomy
- Prior C-section or endometrial ablation
- Cesarean Hysterectomy required
- ALL of these can >> significant bleeding / morbidity
- Placental Abruption = abnormal separation of placenta
- MC cause of coagulopathy in pregnancy
- Presentation = vaginal bleeding + abdominal pain (painful)
- Risk Factors
- Trauma
- COCAINE
- HTN
- Multiple gestations
- Dx = clinical exam
- Mx
- Monitor vital signs
- Fluid administration (make up for bleeding)
- Monitor fetal heart rates
- DELIVERY if severe hemorrhage
- Complications
- blue/purple uterus serosa (if blood penetrates uterus)
- Hemorrhage
- RhD hemolytic anemia in neonate
- DIC, depleted serum fibrinogen, low platelets
- Management of Acute Blood Loss / Hemorrhage
- IVF
- 1:1:1 ratio (to avoid dilution of clotting proteins)
- 1 unit FFP
- 1 unit PRBCs
- 1 unit Platelets
- Massive Blood Transfusion = > 10 units PRBCs in 24 hours
- 1 unit PRBCs = 200 ccs RBCs
- Should raise Hct by 3-4%
- When to give Transfusion
- Massive Hemorrhage (yes)
- Maternal Hb 6-7 (transfusion recommended)
- Hb 7-8 (consider it)
- Hb 8-10 (only give if symptomatic anemia or ACS)
- Risks of Transfusion
- Infection
- Allergic / Immune reaction
- Volume Overload
- RhoGAM for Rh- moms
- Trauma in Pregnancy
- Causes
- motor vehicle accident (most common)
- Physical violence against women (second most common cause)
- Risks:
- maternal injury/death, placental abruption, uterine rupture, hemorrhage, PROM, preterm labor
- Management
- STABILIZE MOM
- If < 20 weeks, place mother in lateral decubitus tilt position
- Monitor vitals, FHTs (Doppler)
- Ultrasound
- Tocometry at least 4 hours if ≥ 23 weeks
- Then 24 hours if there are any signs of uterine tenderness, contractions, ROM,
nonreassuring fetal status
- Fetal-Maternal Hemorrhage
- Determine Rh status
- If Cardiopulmonary Arrest:
- Attempt resuscitation
- Emergent C-section after 4 minutes of failed resuscitation if in third trimester
- maternal resuscitation is easier after baby is delivered
- Fetal survival not likely if maternal vital signs absent for > 15 minutes
- More favorable if delivered within 5 minutes of loss of maternal circulation
- Uterine Rupture
- Complications

Premature Rupture of Membranes


- Definitions
- Premature Rupture of Membranes (PROM) = ROM before uterine contractions
- Preterm Premature ROM (PPROM) = ROM before 37 weeks (“preterm”)
- Leading cause of neonatal morbidity / mortality
- Prolonged ROM = ROM > 24 hours, regardless of gestational age
- Risk Factors for PROM
- (often there are no risk factors present)
- (anything that weakens chorioamniotic membrane)
- Prior preterm delivery (risk repeat PROM 15-30%)
- Vaginal infection (bacterial vaginosis, STI, etc)
- Uterine distension (multiple gestation, polyhydramnios, myomas)
- Placental Abnormalities (accreta, previa)
- Uterine abnormalities (fibroids, didelphys, short cervix)
- Invasive Procedures (Amniocentesis, Cervical cerclage)
- African American
- Low SES
- Low BMI
- Tobacco / Smoking
- Confirm ROM:
- Presentation
- Leaking fluid (big gush, or steady leaking)
- Confusing...could be urine, vaginal secretions, cervical discharge, semen, perineal sweat
- Diagnostic Methods
- Speculum Exam
- Pooling of clear fluid in vaginal vault
- Ferning
- Nitrazine positive
- amniotic fluid is basic/alkaline (pH > 7.1) = appears BLUE on pH paper
- v. vaginal secretions pH 4.5-6

- + swab for gonorrhea, chlamydia, GBS


- Do NOT do digital exam if membranes are ruptured and mom is not in active labor
- Minimize infection risk
- Other Evaluation
- Non Stress Test (for Fetal Status)

- Ultrasound
- Fetal Presentation / Position
- Biophysical Profile (0-2 points each)
- (Normal = score 8-10)
- Amniotic Fluid Index
- Fetal breathing movements
- Gross motor movement
- Tone
- Non-stress test
- Management
- Expectant management or Delivery?
- Delivery Indications:
- > 34 weeks
- Signs of fetal / maternal infection
- Fetal distress
- Advanced labor
- Evidence of fetal lung maturity
- Expectant Management
- Risk/Benefits of Expectant Management based on Gestational Age
- > 37 weeks (90% will go into labor within the next 24 hours)
- Wait it out
- Or Induce (via Oxytocin)
- Reduces time to delivery
- Decreases Chorioamnionitis, Endometritis, Admission to NICU
- < 37 weeks: need to weigh Risk of Prematurity v. Uterine Infection
- Late Preterm (34 - 36.6 weeks)
- Induce labor once ROM is confirmed
- C-Section for Breech fetus
- Early Preterm (< 34 weeks)
- Risk prematurity > uterine infection
- If infection is present >> DELIVERY
- Uterine tenderness, fevers, or high WBC
- No infection:
1. Admit to inpatient
- Ultrasound (amniotic fluid volume)
- Non-stress testing
2. Corticosteroids (to enhance lung maturity)
3. Antibiotics
- to increase latency between ROM and spontaneous labor
- NOT to treat an infection (they’re given bc they’re proven to
increase latency)
4. Induce Delivery at 32-34 weeks
- But if ever see uterine infection, >> DELIVERY
- Antibiotics
- GBS prophylaxis (stop if GBS culture comes back negative)
- Broad spectrum antibiotics (like Erythromycin + Ampicillin)
- Corticosteroids
- Why? (matures lungs, stimulate surfactant release)
- Reduces Respiratory Distress Syndrome
- Reduces Intravascular Hemorrhage
- Indications for CS:
- < 32 weeks PPROM
- Or < 34 weeks without PPROM
- No signs of chorioamnionitis
- Tocolytics (Muscle relaxants)
- decrease contractions to promote latency
- Goal = delay delivery for 48 hours to allow steroids to promote lung maturity
- Tocolytic Options + AE + Contraindications
- Beta agonists (Terbutaline, Ritodrine)
- AE: hyperglycemia (don’t use in diabetics)
- CCBs (Nifedipine, Verapamil)
- AE: hypotension
- Prostaglandin Synthetase Inhibitors (Indomethacin)
- AE in Mom: Thrombocytopenia, Anemia
- AE in Baby: Necrotizing Enterocolitis (NEC)
- Death of intestinal tissue (survival of 70-80%)
- Magnesium Sulfate
- Also prevents seizures
- Contraindicated in myasthenia gravis
- AE: depressed reflexes, flushing, SOB, Pulmonary edema
- Fetal Monitoring
- Kick Counts
- Fetal Tracings
- Ultrasound (interval growth, Biophysical profile, Presentation)
- Potential Complications
- Fetal Mortality (⅓ < 26 weeks, 15% > 26 weeks)
- Pulmonary Hypoplasia
- Cord prolapse
- MSK deformities
- Placental abruption
- Maternal Postpartum Endometritis

Preterm Labor
- 3 Criteria for “Preterm Labor”
- 20-37 weeks
- Regular contractions
- Cervical change (Effacement, Dilation)
- Risk Factors
- Prior Preterm delivery (20-30% recurrence)
- Multifetal Gestation
- Vaginal infection
- Uterine distension
- Placental abnormalities
- Uterine abnormalities
- Low SES
- Low BMI
- Tobacco
- Presentation
- Menstrual-like cramps, Low dull backache, Abdominal pressure, Pelvic pressure
- Increase/change in vaginal discharge (mucous, watery, light bloody)
- Uterine contractions (often painless)
- Evaluation
- Speculum Exam for ROM
- Ferning? Pooling of fluid? Nitrazine positive?
- Cervix open or closed?
- Digital Cervical exam (dilation?)
- Labs
- Lung Maturity
- Lecithin:Sphingomyelin Ratio > 2
- Lecithin increases ≈ 35 weeks while sphingo stays constant
- Phosphatidylglycerol present (if present, < 5% will develop RDS)
- Lamellar body number density (LBND)
- Best if LBND > 50K (fetal lung maturity)
- Gestational Age:
- < 34 weeks: 32% chance ARDS
- 34-36 weeks: 14%
- > 36 weeks: 2%
- Predict Risk of Preterm Delivery
- LOW likelihood of delivery in the next week IF:
- Fetal Fibronectin (fFN) negative
- Protein produced by trophoblasts and chorioamniotic membranes (“glue” to
maintain integrity of membranes)
- Will be positive when it breaks down and is found in cervical-vaginal fluids
- Cervical length ≥ 30 mm
- GBS
- Abdominal Ultrasound
- Presentation + Position
- Biophysical Profile (including amniotic fluid volume)
- Cervical Length
- Prevention
- 17-a-hydroxyprogesterone caproate
- Weekly injections from 20 - 36 weeks gestation
- Management
- Corticosteroid Use Indications (to develop lungs, decrease hemorrhage risk)
- No signs chorioamnionitis
- ≤ 32 weeks with PPROM
- Or < 34 weeks without PPROM
- Tocolytics
- To delay delivery 48 hours until Corticosteroids can mature the lungs
- Beta agonists, CCBs, Magnesium Sulfate, Indomethacin
- Antibiotic Indications
- GBS Prophylaxis
- Adverse Outcomes
- Significant disabilities
- Mortality (60% if < 25 weeks)
- Cardiovascular abnormalities
- Intracranial hemorrhage
- Hypoglycemia
- Necrotizing Enterocolitis
- Infection
- Retinopathy of prematurity / Blindness
- Fetal Lung Development
- Type II pneumocytes line alveoli and produce phospholipids packaged into lamellar bodies
- Surfactant released from lamellar bodies >> reduces surface tension
- Components: Lecithin + Sphingomyelin + Phosphatidylglycerol
- Phosphatidylglycerol appears later in gestation
- Braxton-Hicks Contractions = painless intermittent contractions without cervical dilation
- Increase in frequency throughout gestation

Fetal Growth Abnormalities


- Macrosomia = > 4500 g
- Large for Gestational Age = > 90th percentile for gestational age
- Intrauterine Growth Restriction = weight < 10th percentile for gestational age
- Detection Methods
- ULTRASOUND
- Fetal Biometry Measurements
1. Biparietal diameter
2. Head circumference
3. Abdominal circumference
4. Femur length
- Fundal height
- Maternal weight gain / size (limited value)
- Doppler Velocimetry of fetal vessels
- Management
- Surveillance
- Delivery when fetal death risk > neonatal death risk (difficult to assess)
- Offer C-Section if estimated fetal weight > 4500 g

Medical / Surgical Conditions in Pregnancy


- Anemia
- Physiologic Anemia happens naturally in pregnancy
- bc plasma volume increases 45% in pregnancy, but RBC volume only increases 35%
- Average Hg 12.5 in pregnancy (v. 14 in non-pregnant)
- Diagnosis by Trimester
- T1: Hb < 11 Hct < 33%
- T2: Hb < 10.5 Hct < 32%
- T3: Hb < 11 Hct < 33%
- Mx
- Iron supplements (if iron deficiency)
- 60 mg elemental iron / day
- or 300 mg Ferrous Sulfate / day
- Folate supplement (if folate deficiency / high MCV)
- 0.4 mg/day (Rx prenatal vitamins contain 1 mg)
- (or 4 g/day if history of NTD)
- When to give Transfusion
- For Massive Hemorrhage
- Maternal Hb 6-7 (transfusion recommended)
- Hb 7-8 (consider it)
- Hb 8-10 (only give if symptomatic anemia or ACS)
- Impact
- Baby: diminished iron stores
- Mother: regular adult anemia (fatigue, etc)
- Preexisting Renal Disease
- Risk associated with:
- High Creatinine > 1.5
- HTN present
- Complications
- Hypertensive complications
- IUGR
- Urinary Tract Disorders
- Asymptomatic Bacteriuria >> Ampicillin, Cephalexin, or Nitrofurantoin 7-10 days
- Acute Cystitis >> same (Amp, Ceph, or Nitrofurantoin)
- Pyelonephritis >> IV hydration + Antibiotics (Cephalosporin, Ampicillin, or Gentamycin)
- Acutely ill (fever, CVA tenderness, malaise, dehydration)
- Impact
- Preterm labor
- Septic Shock in mom
- ARDS
- Nausea/Vomiting of Pregnancy (NVP)
- DDx
- Pregnancy-Related
- Acute fatty liver of Pregnancy
- Preeclampsia, HELLP
- NOT Pregnancy-related
- GI: gastroenteritis, gastroparesis, gallbladder, bowel obstruction, hepatitis, PUD,
pancreatitis, appendicitis
- GU: pyelonephritis, ovarian torsion, kidney stones
- Metabolic: DKA, Porphyria, Addison, Hyperthyroidism
- Neuro: migraines, CNS tumors
- Exam Findings that point to NOT pregnancy related
- Abdominal pain / tenderness (other than mild epigastric discomfort
- Fever, headache
- Abnormal neuro exam
- Goiter
- Management
- DIET: frequent small meals, high carb, low fat, bland/salty diet, clear liquids, rest, fresh air
- Vitamin B6 (Pyridoxine) +/- Doxylamine (first line)
- Antihistamines (H1 blockers), Promethazine, Dimenhydrinate
- Dopamine antagonists (Phenothiazines, Benzamides)
- IVF for dehydration
- Chlorpromazine, Metoclopramide, Odanzetron
- DDx of R Side Abdominal Pain in pregnancy
- Appendicitis (RLQ)
- Good outcome if early diagnosis and treatment
- Evaluation
- WBC, CRP
- Abdominal Ultrasound (imaging of choice, since CT has radiation)
- Tx = prompt appendectomy (delay increases risk of perforation, which increases fetal complications)
- RUQ = cholecystitis, cholelithiasis, hepatic hemorrhage, liver dysfunction (HELLP)
- IBD, Adnexal pain
- Cardiac Disease
- Respiratory Disorders
- Surgical Abdomen

Post-Term Pregnancy
- Normal Period of Gestation
- Complications of Prolonged Gestation
- Evaluation
- Management

Multifetal Gestation
- Risk Factors
- Embryology
- Diagnosis
- Management
- Complications (Fetal / Maternal)

MODULE 7: Menstruation + Contraception


Normal and Abnormal Bleeding
- Normal Menstrual Cycle
- Normal = predictable and regulated
- 21-35 day cycles
- Flow 4-6 days
- Loss of ≈ 30 cc menstrual blood
- Physiology
- Ovarian dominant follicle secretes estradiol
- Follicular Phase
- LH levels increase >> LH surge on day 11-13
- >> ovulation
- After ovulation, dominant follicle becomes corpus luteum
- Luteal Phase
- Corpus luteum produces Progesterone (+ some estrogen)
- Negatively feeds back to decrease FSH/LH
- Progesterone develops the secretory uterine lining
- FSH/LH are at lowest levels by the end of the luteal phase
- Feedback >> rise in preparation for next cycle
- No fertilization:
- Corpus luteum breaks down >> decreased Progesterone >> uterine wall breaks down
- >> Menses
- Abnormal Uterine Bleeding
- Definition = menstrual flow outside of normal regularity, frequency, volume, or duration
- Most cases in 5-10 years before menopause
- Pathophysiology
- Causes
- PALM-COEIN
- Polyps
- Adenomyosis
- Leiomyoma
- Malignancy
- Coagulopathy (like vWF)
- Ovarian dysfunction (PCOS, perimenopausal anovulation)
- Endometrial processes
- Iatrogenic
- Not yet classified
- Pregnancy
- Gonorrhea, Chlamydia
- Evaluation
- History: heaviness of periods; pattern of bleeding
- Exam:
- Excessive weight gain
- Signs of:
- PCOS (hirsutism, acne)
- Thyroid disease
- Insulin resistance
- Bleeding Disorder (petechiae, ecchymosis, skin pallor, swollen joints)
- Pelvic Exam (including bimanual)
- Endometrial Biopsy
- Low index of suspicion to rule out endometrial cancer for:
- Women > 40 yo
- Risk factors present (obesity, diabetes, etc)
- Labs:
- CBC (for anemia)
- TSH (rule out thyroid disease)
- PREGNANCY TEST in reproductive age women
- Pelvic Ultrasound
- Management
- Initial Options
- OCPs, Cyclic Progesterone
- Levonorgestrel IUD
- Endometrial Ablation (but rule out endometrial hyperplasia first with endometrial biopsy)
- Surgical Options
- Possibly needed if due to anatomic source, like Polyp or Fibroid
- Hysterectomy if all else fails
- Leiomyoma (Fibroids) (was case in module)
- Evaluation
- Exam + Ultrasound
- +/- CT or MRI
- Hysteroscopy
- Treatment
- Medical:
- Progestin supplementation
- Iron if anemic
- GnRH agonists before planned hysterectomy (to reduce fibroid size)
- Surgical
- Myomectomy (if may still want children)
- Hysterectomy (if don’t want more children)
- Articles in Modules
- Mx of AUB due to Ovulatory Dysfunction (ACOG)
- Progestin-only Contraception
- Combined hormonal contraception
- Endometrial ablation or Hysterectomy if all else fails
- Mx of Acute AUB in Non-pregnant Reproductive-Aged Women (ACOG)
- Classify Cause by PALM-COEIN system
- Management
- Initially Medical
- IV conjugated equine estrogen
- OCPs, Oral Progestins
- Tranexamic acid
- Surgical Treatment based on stability, bleeding severity, contraindications to medications,
lack of response to medications, underlying medical conditions, and desire for future fertility
- Transition to long-term maintenance therapy after acute bleeding is controlled

Uterine Leiomyoma
- Prevalence
- Presentation
- Diagnosis
- Management

Amenorrhea
- Amenorrhea = absence of menstruation
- Primary Amenorrhea = no menarche by 16 years old
- Secondary Amenorrhea = no menstruation for 3-6 months or 3 cycles
- Oligomenorrhea = bleeding less frequently than every 35 days
- Pathophysiology
- Causes
- Pregnancy (MC cause)
- Hypothalamic-Pituitary dysfunction
- Functional (weight loss, excessive exercise, obesity)
- Drugs, Psychogenic causes (anxiety, anorexia nervosa), head injury, chronic illness
- Neoplastic (Prolactin-secreting pituitary adenoma, Craniopharyngioma, Hypothalamic hamartoma)
- Ovarian dysfunction
- Turner syndrome; X chromosome deletion
- Gonadotropin-resistant ovary syndrome (Savage syndrome)
- Premature natural menopause
- Autoimmune ovarian failure
- Altered Genital outflow tract
- Imperforate hymen, transverse vaginal septum
- Asherman Syndrome (MC cause of secondary amenorrhea)
- Scarring of endometrium after D&C to remove products of pregnancy, or adhesions
- Evaluation
- H&P (including Tanner staging, hirsutism)
- TSH (rule out subclinical hypothyroidism)
- FSH (high in women < 40 can mean primary ovarian insuficiency)
- Prolactin
- Autoimmune antibodies
- Progesterone Challenge test (give 10-14 days progesterone, and it should induce withdrawal bleeding a
week after completing the oral course)
- Yes bleeding = no problem with estrogen’s effect on the endometrium
- Cause probably anovulatory or oligo-ovulatory
- No bleeding = hypoestrogenic, Asherman syndrome, outflow tract obstruction
- Amenorrhea Dx / Mx (ACOG Article in Module)
- Metformin for PCOS patients (A recommendation)
- C Recommendations
- Exclude Pregnancy
- Weight restoration, nutritional rehab, and decreased exercise for patients with functional
hypothalamic amenorrhea (and female athlete triad)
- Evaluate overweight PCOS patients for glucose intolerance, dyslipidemia, and overall cardiovascular
risk
- Diagnosis
- H&P, Pregnancy test, LH, FSH, TSH, Prolactin, Ultrasound, etc
- Pregnant = pregnancy test +
- Thyroid dysfunction = abnormal TSH
- Pituitary Adenoma = abnormal prolactin level >> MRI
- No Uterus
- Androgen insensitivity syndrome, Mullerian agenesis
- Functional Amenorrhea (Energy deficit) = low FSH/LH
- Primary Ovarian Deficiency = high FSH/LH
- Turner syndrome
- PCOS = hyperandrogenism, high LH, low FSH
- Outflow Tract Obstruction = normal FSH/LH and all other causes excluded

PMS / PMDD
- Criteria for Diagnosis
- PMS Criteria (at least 1 symptom during 5 days before menses for last 3 menstural cycles)

- PMDD Criteria
- For majority of menstrual cycles, at least 5 symptoms present in week before menses, and improve
in first days of menses
- 1+ of the following:
- Marked affective lability (mood swings, sad/tearful, increased sensitivity to rejection)
- Marked irritability, anger, or increased interpersonal conflicts
- Marked depressed mood, feeling of hopelessness, or self-depreciating thoughts
- Marked anxiety, tension, and/or feelings of being keyed up or on edge
- AND 1+ of the following:
- Decreased interest in usual activities (work, school, friends, hobbies)
- Subjective difficulty concentrating
- Lethargy, easy fatiguability, marked lack of energy
- Marked change in appetite, overeating, or specific food cravings
- Hypersomnia or insomnia
- Treatment Options
- Nonpharm:
- Fruits, vegetables (limit sugars, fats, salt, caffeine, alcohol)
- Aerobic exercise
- Calcium or Magnesium supplements
- Pharm:
- NSAIDs for dysmenorrhea, breast pain, leg edema in PMS
- OCPs
- SSRIs for PMDD (GOLD STANDARD for PMDD)
- ACOG Article in Module (PMD/PMDD)
- SSRIs for first line treatment in PMS / PMDD (A recommendation)
- OCPs are effective for PMS / PMDD (A recommendation)
- Calcium supplements 1000 - 1200 mg/day may help PMS (B)
- CBT may improve PMS / PMDD (B)
- Daily Record of Severity of Problems is a useful tool to help diagnose PMS / PMDD (C)

Contraception / Sterilization
- Pathologic basis for contraception
- Mechanisms of Methods:
- Prevent Ovulation
- Combined OCPs, Medroxyprogesterone acetate injections (Depo), Etonogesterel implants
- Lactational amenorrhea (infant suckling interrupts GnRH secretion >> low LH/FSH >> low
follicle development)
- Prevent Fertilization
- Keeping millions of sperm from contacting the oocyte
- Physical Barriers:
- condoms, diaphragms, sterilization
- thickened cervical mucus (pills, implants, injections, progestin-only IUDs)
- Chemical Barriers:
- Spermicide (deposited near cervix before sex and needs to be in place for at least an
hour afterwards
- Copper IUD (causes local inflammation that’s toxic to sperm and egg)
- Temporal methods
- Fertility Awareness (avoid intercourse for 5 days before to 1 day after ovulation)
- Emergency contraceptives (purely a temporal barrier and doesn’t interact with
established pregnancy)
- Ulipristal acetate (a selective progesterone receptor modulator)
- Copper IUD can be used up to 5 days after unprotected sex as emergency
contraception
- Prevent Implantation
- Copper IUD
- Levonorgestrel IUD
- Progestin
- Etonorgestrel, Levonorgestrel, Norgestimate
- Mechanism
- Causes negative feedback on Hypothalamus >> inhibits LH and LH surge >> inhibits
ovulation
- Thickens cervical mucous
- Creates thin resting endometrium
- May interfere with egg transport via tubal peristalsis
- Estrogen
- Ethanol Estradiol, or Estradiol valerate
- Mechanism
- Negative feedback >> FSH suppression >> Prevents follicle recruitment, maturation, and
ovulation
- Potentiates concentration of progesterone receptors
- Balanced endometrial proliferation (minimizes irregular bleeding)
- Methods
- Hormonal
- Estrogen / Progesterone
- OCPs, Transdermal Patch, Vaginal ring
- Progesterone Only
- Progesterone pills
- Etonogestrel implant, Medroxyprogesterone injections (Depo-Provera)
- Levonorgestrel IUD
- Non-Hormonal
- Lactational amenorrhea
- Fertility awareness methods
- Barrier methods (condoms, diaphragms, spermicide)
- Sterilization
- Copper IUD
- Comparing Methods (Effectiveness, Benefits/Risk, Financial considerations)
- Male:
- Condom (18 / 2% failure rate)
- Withdrawal (22 / 4)
- Female
- LARC
- IUD (Copper 0.6%; LNG 0.2%)
- Implantable (0.05)
- Injectable (6 / 0.2)
- Hormonal (ALL 9 / 0.3%)
- OCP Combined or Progestin only
- Patch, Ring
- Barriers
- Condom (21 / 5)
- Sponge (24 / 20)
- Diaphragm (12 / 6), Spermicide (28 / 18)
- Couple
- Fertility Awareness (24 / 0.4 - 5%)
- Coitus Interruptus (22%)
- Permanent Option
- Sterilization
- Emergency Contraception
- Progesterone
- Ulipristal
- Copper IUD
- Methods of Sterilization
- Male = Vasectomy (compromise of vas deferens)
- Safer, less expensive, and more effective than female sterilization
- More reversible than female sterilization
- 1% failure rate
- Must confirm azoospermia by semen analysis (98% at 6 months)
- Female = hysterectomy, fallopian cautery / clips / rings / ligation / etc
- Reversal is high cost and low success rate
- Risks / Benefits of Procedures
- Potential surgical complications
- Failure rates
- Reversibility

Hirsutism / Virilization
- Normal Variations of Secondary Sex Characteristics
- Hirsutism = presence of coarse pigmented hair on the face, chest, upper back, or abdomen in a female as a result
of excessive androgen production (hyperandrogenism)
- Virilization =
- Physiology
- Types of Androgens: Testosterone, DHEAS, Androstenedione
- Androgens are produced in the:
- Adrenal glands
- Ovaries (in theca cells)
- extraglandular tissue
- Hyperandrogen + PCOS Causes
- Increased number theca cells, or increased LH receptors on theca cells
- High LH stimulation of theca cells, or increased sensitivity of theca cells to LH
- Potentiation of LH by hyperinsulinemia
- Causes
- Ovarian
- PCOS = most common cause of excess androgens and hirsutism in women
- Oligomenorhea / amenorrhea, acne, hirsutism, infertility, obesity
- Excess androgens, high LH, low FSH, high Testosterone
- Ovarian tumors
- Adrenal
- Congenital Adrenal Hyperplasia (2nd most common cause behind PCOS)
- Cushing Syndrome, Adrenal neoplasms
- Pituitary
- Pharm
- Danazol (used for suppression of pelvic endometriosis)
- OCPs (Progestins)
- Evaluation
- H&P + Pelvic Exam
- Hyperandrogenic symptoms?
- New constitutional symptoms?
- Onset?
- Normal Exam + Mild Symptoms >>
- Trial medication 6 months
- If no improvement, >> Testosterone testing
- Moderate symptoms concerning for PCOS >>
- Total Testosterone level
- High > 200: order Hormone testing + Imaging
- Not high < 200: order TSH, Prolactin, 17-OHP, +/- Cushing testing
- Rapid onset palpable mass >>
- Hormonal Workup
- Imaging
- Management
- Non-Medical
- Shaving, plucking, waxing, depilatory creams
- Electrolysis / Laser hair removal
- Combined OCPs
- Decrease adrenal / ovarian androgens (>> decrease hair growth)
- Desogestrel, Gestodene, Norgestimate
- PCOS management If she wants to become pregnant:
- Not OCPs obviously if she wants pregnancy, so:
- Weight reduction
- Ovulation induction with Clomiphene
- Exogenous gonadotropins
- Ovarian surgery
- Other options
- Oral Progestins (suppress LH)
- Oral Estrogens
- increases sex hormone binding globulin in the liver >> decreased testosterone
- Medroxyprogesterone
- Decreases GnRH >> decreases testosterone
- Glucocorticoid (For Adrenal Hyperandrogenism)
- Ketoconazole
- Spironolactone

MODULE 8: Menopause, Oncology, Pelvic Support


Pelvic Support Defects and Urinary Incontinence
- Primary Support of Pelvic Floor
- Levator Ani muscles (Iliococcygeus, Pubococcygeus, and Puborectalis)
- Endopelvic Fascia (secondary support)
- Uterosacral ligaments, Cardinal ligaments, and Arcus tendineus
- Levels of Support
- 1: Apical support
- Cardinal-Uterosacral ligaments (apical attachment to uterus and sacrum)
- Defect >> uterovaginal prolapse
- 2: Mid-vaginal
- Arcus tendinous fascia (overlying levator ani)
- Support upper ⅔ of the vagina laterally
- Defect >> cystocele
- 3: Distal Vaginal
- Urogenital diaphragm + Perineal body
- Defect >> distal rectocele
- Pelvic Organ Prolapse = descent of pelvic structure(s) to or through the vaginal opening
- Risk Factors
- AGING and VAGINAL DELIVERY (most common)
- Menopause (less collagen)
- Chronic increased abdominal pressure, Constipation, Obesity
- Pelvic floor trauma, Connective tissue disorders
- Presentation
- Bulge symptoms
- Incontinence
- Dyspareunia
- Types
- Cystocele = bladder prolapse through vagina
- Rectocele = rectum prolapse through vagina
- Vaginal Vault Prolapse = descent of vaginal vault post-hysterectomy
- Uterine Prolapse = uterine descent through vagina
- Treatment
- Expectant Management (treat only if symptomatic or causing problems)
- Pelvic floor Physical Therapy
- Vaginal pessaries
- Surgical Management (but there is risk of recurrent prolapse with surgery)
- Hysterectomy
- Reconstruction
- Incontinence
- Involuntary leakage of urine
- Physiology
- Urine Storage = Sympathetic
- Contraction of sphincter by pudendal nerve
- Contraction of smooth muscle at neck of uterus to keep it closed
- Micturition = Parasympathetic
- Relaxation of sphincter by pudendal nerve
- Contraction of smooth muscle of the bladder and relaxation of smooth muscle at the neck of
the baldder (hypogastric nerve)
- Types of Incontinence
- Stress Incontinence
- Happens with increased abdominal pressure (coughing, sneezing, laughing, weight lifting,
etc)
- Causes
- Urethral hypermobility (insufficient support tissue)
- Intrinsic sphincter deficiency (loss of urethral mucosal and muscular tone)
- Tx
- Kegel exercises, PT
- Pessaries, Urethral bulking agents, Mid-urethral sling
- ACOG Article in Module
- Evaluation:
- H&P + assess for Pelvic Organ Prolapse
- Urinalysis, Postvoid residual urine volume
- Cough stress test, Urethral mobility
- Urge = “Overactive Bladder”
- Urge to urinate followed by involuntary leakage
- Cause = Detrusor overactivity >> involuntary detrusor contractions
- Tx
- Bladder training
- Prompted voiding
- Beta agonists (act on beta receptors to enhance detrusor relaxation)
- Antimuscarinics (decrease detrusor contractions)
- AE = dry mouth, blurred vision, tachycardia, constipation, drowsiness
- Mixed = stress + urge incontinence symptoms
- Overflow
- Incomplete bladder emptying
- Cause:
- Detrusor underactivity (spinal nerve damage, neuropathy, etc)
- Bladder outlet obstruction (fibroids, pelvic prolapse, etc)
- Tx
- Treat cause
- Intermittent straight catheterization (to empty the not-emptying bladder)
- Evaluation
- History + Exam (evaluate for pelvic organ prolapse)
- Postvoid residual urine volume
- Urodynamic testing (measure pressure/volume of bladder filling and flow rate of emptying)
- Cystourethroscopy (for lesions, foreign bodies, malformations, strictures)
- Treatment for ALL Types:
- Weight loss
- Normalize fluid intake
- Decrease bladder irritants
- Minimize constipation
- Smoking cessation
- UTI
- Risk Factors
- Upper UTI
- Diagnosis
- Treatment
- Lower UTI
- Diagnosis
- Treatment

Menopause
- Menopause = 12 months of amenorrhea (on depletion of ovarian follicles)
- Perimenopause = transition from reproductive age to menopause (about 4 years before final period)
- Physiologic Changes in the HPO axis in perimenopause / menopause
- Hypothalamus >> [GnRH] >> Pituitary >> [LH/FSH] >> Ovary >> Estrogen + inhibin
- Inhibin >> negative feedback to hypothalamus and pituitary
- Perimenopause
- First part of follicular phase shortens
- Increased anovulatory cycles >> abnormal uterine bleeding
- Increased risk endometrial hyperplasia and cancer (unopposed estrogen due to anovulation)
- Menopause:
- Depletion of ovarian follicles
- >> low estrogen production
- Feedback >> GnRH release >> high FSH/LH
- Presentation
- Vasomotor symptoms
- Hot Flashes, Sweating
- Palpitations
- Anxiety
- Sleep disturbances
- Increased risk bone loss
- Due to RANK-L, osteoclasts, bone resorption
- Increased LDL, Cardiovascular disease
- Mastalgia
- Vulvovaginal atrophy
- Dryness, itching, dyspareunia
- By low estrogen and decreased collagen and adipose tissue
- Incontinence, UTIs
- Depression
- Management
- Menopausal Hormone Therapy
- Estrogen AND Progesterone (to prevent uterine cancer)
- If no uterus, then don’t need Progesterone; can just use Estrogen
- Minimal dose for shortest amount of time possible
- Contraindications to HT:
- Undiagnosed genital bleeding
- Known estrogen-dependent neoplasia
- Active DVT, PE, or history of those
- Active stroke, MI
- Liver disease / dysfunction
- Known / suspected pregnancy
- Gabapentin
- Clonidine
- SSRIs / SNRIs
- Vaginal Estrogen (for vaginal symptoms)
- Risks of Treatments:
- Combined HT: breast cancer, stroke, CVD, VTE risk
- Estrogen only: uterine cancer risk
- Progesterone only: depression, weight gain
- ACOG Module Articles:
- Tx of Menopause Symptoms
- Vasomotor Treatment
- Systemic Hormone Therapy +/- Progestin
- But raises risk for VTE and breast cancer
- Transdermal Estrogen may have lower risk VTE than oral estrogen
- DON’T routinely discontinue HT at age 65
- individualize therapy, bc some women may still need it after 65
- Estrogen + SERM (Bazedoxifene) for women with uterus
- Paroxetine = the only FDA-approved med for VMS management
- Though venlafaxine, clonidine, and gabapentin are all more effective than placebo
- Botanicals, natural products, herbs, etc have not been shown to be more effective
than placebo
- Vulvovaginal Atrophy
- Vaginal Estrogen (if no indications for systemic HT)
- Oral SERM Ospemifene = for dyspareunia associated with VVA
- Bioidentical Hormone Therapy
- = plant- or animal-derived hormones
- Lack of evidence to support bioidentical hormones over conventional menopause hormone therapy
- Conventional hormone therapy is preferred
- No good evidence to support individualized hormone therapy based on salivary, serum, or urine
testing

Gynecological Neoplasia
- Cervical Cancer
- (discussed in earlier module)
- Vulvar Cancer
- 90% SCC (then melanoma)
- Risk Factors
- Age
- HPV
- Smoking
- Lichen Sclerosus
- Presentation
- Vulvar pruritus
- red/white ulcerative or exophytic lesion
- Evaluation
- Vulvar BIOPSY (Punch biopsy, colposcopy)
- Indications for Vulvar Biopsy
- Complaint of vulvar symptoms (cancer won’t always have an exophytic lesion)
- Persistent pruritus, burning, or pain
- Visible lesions
- Lymph Nodes involved:
- Inguinal, Femoral nodes
- Deep Pelvic nodes (if from anterior 1/3 of vulva)
- Treatment Options
- Radical Vulvectomy with bilateral node dissections (if very invasive)
- Or more conservative operations for unifocal lesions
- Postop radiation to decrease groin recurrence
- Uterine Cancer
- Usually Adenocarcinoma
- Risk Factors
- UNOPPOSED ESTROGEN
- Tamoxifen
- Obesity, Older age, Nulliparity, Infertility history
- Early menarche, Late Menopause
- Presentation
- Abnormal uterine bleeding + risk factors
- Often postmenopausal bleeding
- Causes of Endometrial hyperplasia / Cancer
- Diagnosis
- BIOPSY
- Transvaginal Ultrasound
- +/- CA-125 (often elevated)
- Management
- HYSTERECTOMY +/- Radiation
- Staging Impact on Management / Prognosis
- Endometrial Hyperplasia:
- D&C sample of endometrium to exclude coexisting cancer
- Progestins high-dose (for women who desire future fertility)
- Levonorgestrel IUD
- Hysterectomy = definitive therapy (after completion of childbearing)
- Stage 1 Cancer:
- Hysterectomy only
- Radiation may reduce recurrence, but doesn’t improve survival
- Stage 3c - 4 (Metastasis):
- Hysterectomy + RADIATION
- Recurrent Disease:
- Hysterectomy + RADIATION
- Progestin can also help
- Ovarian Cancer
- Growth Factors Associated
- Fibroblast Growth Factor (FGF)
- Platelet Derived GF (PDGF)
- Vascular Endothelial GF (VEGF)
- Risk Factors
- Older Age, Nulliparity, Infertility history
- Endometriosis
- BRCA, Lynch syndrome
- OCPs decrease risk of ovarian cancer
- Early Warning Signs of Ovarian Cancer
- Increased abdominal size, abdominal bloating / pain
- Fatigue, unexplained weight loss
- Indigestion, constipation, urinary frequency, incontinence
- Back pain
- Evaluation
- Ultrasound suspicious masses
- (+/- MRI, CT)
- CA125 Ovarian Biomarker
- But can be falsely elevated in other conditions that cause inflammation:
- Endometriosis, Uterine Fibroids, PID
- Cirrhosis, Pleural/Peritoneal fluid
- Cancer of uterus, breast, lung, pancreas
- HE4 another biomarker
- Associations:
- BRCA 1 / 2
- Can consider bilateral salpingo-ophorectomy to reduce risk
- Peutz Jegers Syndrome (+ mucocutaneous pigmented lesions)
- Lynch Syndrome (risk colon, uterine, ovarian, and stomach cancer)
- Histologic Categories
- Epithelial tumors (from fallopian tubes and surface epithelium)
- 60% High Grade Serous Carcinoma (@ TP53 or BRCA)
- 10% Endometroid Carcinomas (@ Lynch syndrome)
- 10% Clear Cell Carcinoma (@ endometriosis)
- 10% Mucinous Carcinoma (@ perimenopausal women)
- 3% Low Grade Serous Carcinoma
- Hyalinized stroma with psammoma bodies

- Germ Cell tumors (from primordial germ cells of the ovary)


- 95% Mature Teratoma / Dermoid (benign)
- Contains ectoderm, endoderm, and mesoderm
- Malignant:
- Immature Teratomas (2%)
- Ectodermal component undergoes malignant transformation
- Dysgerminomas (like seminomas; have LDH)
- Yolk Sac Tumors (young girls; Schiller Duval bodies; AFP)
- Mixed Germ Cell Tumors
- Sex Cord Stromal tumors (from ovarian stroma or follicles)
- Granulosa Cell Tumors
- Secrete estrogen
- biomarkeres inhibin A/B
- Call-Exner bodies
- Sertoli Leydig
- Secrete androgens or androgen precursors
- Fibromas (benign)
- MC stromal tumor
- +/- Meig’s Syndrome: ascites, pleural effusions, fibroma
- Thecomas (usually benign)
- Solid, often very large tumors
- 90% Epithelial types
- Most common type of ovarian cancer = Serous cystadenocarcinoma
- Impact of Staging on Management
- Most commonly diagnosed at stage 3/4 (since earlier stages are asymptomatic)
- SURGERY + CHEMO usually (Paclitaxel + Carboplatin or Cisplatin)
- With cytoreductive surgery or “TUMOR DEBULKING” to decrease tumor size before chemo
- Staging of Ovarian Cancer

- Treatment of
- Simple Ovarian Cyst (Follicular Cyst):
- Resolves in 6 weeks spontaneously
- OCP may prevent recurrence

You might also like